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ABSTRACT 
 The aim of this master thesis was to investigate the ability of selected individual 
carcinogenic polycyclic aromatic hydrocarbons (c-PAHs: benzo[a]pyrene, B[a]P; 
dibenzo[a,l]pyrene, DB[a,l]P), an artificial mixture of c-PAHs (c-PAH mix) and extractable 
organic matter (EOM) from urban air particulate matter (PM) to induce oxidative damage 
in vitro. Two cell lines (human hepatoma cells, HepG2, and human diploid lung fibroblasts, 
HEL) were treated for 24 h and 48 h with various concentrations of compounds or 
mixtures. The studied oxidative stress markers included 8-oxodeoxyguanosine (8-oxodG) 
as a marker of oxidative DNA damage, 15-F2t-isoprostane (15-F2t-IsoP) as a marker of lipid 
peroxidation and protein carbonyl groups as a marker of oxidative damage to proteins. 
The response of the cell lines to the tested compounds and mixtures differed substantially. 
In summary the results demonstrate the ability of EOM to induce oxidative damage to DNA 
and lipids after 24 h of treatment and to proteins after 48 h, in HepG2 cells. The effect of c-
PAHs was substantially less. The induction of oxidative damage by c-PAHs and EOM in 
HEL cells was weak. Since c-PAHs had lower ability to cause oxidative damage that was 
limited only to longer incubation periods, it is probable that other components of EOM are 
responsible for increased levels of oxidative markers in HepG2 cells. 
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1 INTRODUCTION 
 “Unlimited and free access to clean air of acceptable quality is a fundamental human 
necessity and right” (WHO 2004). Despite this statement, the quality of urban air, particularly 
in large cities, is less than optimal. It contains a very complex mixture of chemical compounds 
originating from many different sources. Among others, polycyclic aromatic hydrocarbons 
(PAHs) represent a group of organic pollutants of particular interest as many of them are 
known or suspected human mutagens and carcinogens (IARC, in preparation). In the ambient 
air, PAHs are mostly adsorbed on the surface of dust particles. Particulate air pollution thus 
poses a threat to human health. Numerous epidemiological studies have shown that particulate 
pollution is related to adverse health outcomes of exposed populations. However, 
the mechanisms by which particles influence human health are only poorly understood. 
Therefore, there is a need for toxicological studies, which would identify specific components 
or sources of the air pollution mainly responsible for the adverse health effects. One 
hypothesis is that airborne particles induce oxidative stress which underlies much of their 
adverse health effects (DONALDSON et al. 2003, SHI et al. 2003). 
 The aims of this master thesis were: 
1. To identify the potential contribution of carcinogenic polycyclic aromatic hydrocarbons 
(c-PAHs) as benzo[a]pyrene (B[a]P) and dibenzo[a,l]pyrene DB[a,l]P, an artificial 
mixture of c-PAHs (c-PAH mix) and extractable organic matter (EOM) from urban air 
particulate matter (PM) to oxidative damage to macromolecules. 
2. To assess the response of two different cell models to exposure to the tested compounds 
and mixtures: a hepatoma cell line (HepG2 cells) and human diploid lung fibroblasts 
(HEL cells). 
3. To compare oxidative damage to DNA, lipids and proteins by the analysis of three 
different markers of oxidative stress including 8-oxodeoxyguanosine (8-oxodG, a marker 
of oxidative damage to DNA), 15-F2t-isoprostane (15-F2t-IsoP, a marker of lipid 
peroxidation) and protein carbonyl levels (a marker of protein oxidation). 
 To achieve these goals, the cell lines were treated with different concentrations of 
B[a]P and DB[a,l]P, with a mixture of c-PAHs and with EOM for 24 h and 48 h.  The cell 
lines differing in the metabolic activity simulate target tissues for the effect of c-PAHs and 
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PM: HepG2 cells capable of efficient bioactivation of many xenobiotics including c-PAHs are 
widely used in toxicology instead of human hepatocytes. Human lung fibroblasts were chosen 
as a representative of lung tissue, where the deposition of PM and PM-mediated c-PAHs 
occurs. Since oxidative stress is a very complex process, three biomarkers were employed to 
have a better chance of revealing some of the mechanisms of oxidative stress induction by 
the selected compounds. 
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2 LITERATURE REVIEW  
2.1 Polycyclic aromatic hydrocarbons (PAHs) 
Polycyclic aromatic hydrocarbons are a large group of diverse organic compounds 
with two or more fused aromatic rings of carbon and hydrogen atoms. They are highly 
lipophilic thus having a relatively low solubility in water. Physical and chemical properties 
of PAHs vary with molecular weight. The larger compounds are less water-soluble and less 
volatile. PAHs are ubiquitous pollutants formed mainly as a result of pyrolytic processes, 
especially the incomplete combustion of organic materials during industrial and other 
human activities, such as processing of coal and crude oil, asphalt production, combustion 
of coal, wood or natural gas, vehicle traffic, waste incineration, cooking and tobacco 
smoking. Natural PAHs sources include plant synthesis, volcanic eruptions and forest and 
prairie fires. They are also present in crude oil and coal tar (WHO 1987, STRAIF et al.  
2005). 
Distribution of PAHs depends on the material being combusted, e.g. coal burning 
produces a different mixture of PAHs than motor-fuel combustion or a forest fire, making 
the compounds potentially useful as markers of the specific source. There have been several 
studies concerning this problem. According to NIELSEN et al. (1996) and REHWAGEN 
et al. (2005) the high ratio of benzo[g,h,i]perylene (B[g,h,i]P) to benzo[a]pyrene (B[a]P) 
and also coronene to B[a]P indicates the traffic as a main source of PAHs pollution while 
low B[g,h,i]P to I[1,2,3-c,d]P ratio signify a higher contribution from non-traffic sources. 
Generally, B[g,h,i]P and coronene indicate traffic emissions while high level of 
benz[a]anthracene (B[a]A) indicates higher emissions from wood combustion and domestic 
heating (LI and KAMENS 1993). 
When released to the environment, PAHs usually enter the air where they often bind 
to dust particles. Whether adsorbed on particulate matter or present in water, PAHs can 
undergo photodecomposition when exposed to sunlight. In the atmosphere, PAHs can also 
react with other pollutants such as ozone, nitrogen and sulphur oxides, yielding diones, 
nitro- and dinitro- PAHs, and sulphonic acids, respectively (WHO, 2000). PAHs and their 
derivatives are pollutants of primary concern, since some of them are known or suspected 
human carcinogens (IARC, in preparation). 
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The major sources of PAHs for general population include inhalation of polluted 
ambient air, smoking and consumption of PAHs in food such as sweets, cereals, bread or 
processed food, as well as fruit and vegetables grown in contaminated soil. Various 
cooking processes such as roasting, frying, grilling or smoking generate more PAHs thus 
increasing the amount of total PAHs in food (PHILLIPS 1999). According to the study 
conducted in Copenhagen between the years 1984 and 1986, food constituted the major 
source of PAHs for non-smokers (DE VOS et al. 1990). However, according to ČERNÁ 
et al. (1999) the exposure to B[a]P from ambient air in the Czech Republic was four times 
higher than the dietary intake, thus indicating that air pollution is the major source of 
c-PAHs exposure for the Czech population. In both studies the major contribution of PAHs 
exposure for smokers was attributed to cigarette smoking. Moreover, in labours working in 
industries such as mining, oil refining and metal working as well as in workers inhaling 
engine exhausts, such as mechanics, street vendors and motor vehicle drivers an 
occupational exposure may occur (STRAIF et al. 2005). 
After they enter the organism, either inhaled or present in diet, PAHs are rapidly 
distributed to most internal organs. The process takes from minutes to hours and the highest 
levels of PAHs were found in liver (WHO 2000). PAHs are also deposited in mammary 
and other fatty tissues (MODICA et al. 1983). Moreover, B[a]P can readily cross 
the placental barrier (NEUBERT and TAPKEN 1988, HATCH et al. 1990, WITHEY et al. 
1993), thus exhibiting its fetal toxicity. Carcinogenic PAHs themselves, as well as most 
chemical carcinogens in the environment, are chemically inert and require metabolic 
activation to exhibit their carcinogenic effects (GUENGERICH and SHIMADA 1991).  
 Metabolic activation of PAHs 
Upon entering the organism, c-PAHs undergo metabolic transformation. They are 
converted to electrophilic species by cytochrome P450s enzymes. These reactive 
electrophilic species are capable of interacting with the nucleophilic sites of the DNA bases 
to form adducts. The formation and persistence of carcinogen-DNA adducts are believed to 
be critical events for the initiation of tumorigenesis in target cells (NESNOW et al. 1998b, 
1998c, BINKOVÁ and ŠRÁM 2004). The bioactivation of polycyclic aromatic 
hydrocarbons by cytochrome P450s enzymes represents phase I reactions of the xenobiotic 
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metabolism. The aim of this process is to convert highly lipophilic chemicals into more 
water soluble products which are then more easily excreted from the organism. During 
the phase II reactions the polar functional groups of phase I metabolites are conjugated with 
glucuronic acid, sulphonates, glutathione (GSH) or with some amino acids. The products of 
these reactions are usually inactive and ready to be excreted from the organism in faeces or 
urine. However, the phase I reaction metabolites tend to be highly reactive and capable of 
binding covalently to cellular macromolecules. The whole mechanism has been best 
characterised for B[a]P (Figure 1.) which is one of the most often studied c-PAHs. Upon 
entering the cell, B[a]P (as well as other c-PAHs) binds to the cytosolic aryl hydrocarbon 
receptor (AhR). The complex then translocates to the nucleus where it forms heterodimer 
with AhR nuclear translocator (ARNT). Heterodimers activate transcription of genes 
encoding cytochromes P450 1A1 and 1B1 (also CYP1A1, CYP1B1) (SHIMADA and 
FUJII-KURIYAMA 2004). Cytochrome P450 enzymes are a superfamily of haem-
containing monooxygenases, responsible for the phase I metabolism of a wide range of 
substrates (drugs, xenobiotics and steroids). They insert an atom of molecular oxygen into 
their substrates, resulting in increased hydrophilicity. In the case of most c-PAHs, CYP1A1 
and CYP1B1 are responsible for the formation of polar hydroxy and epoxy derivatives 
which can be further oxidised by epoxide hydrolase (EH) to form dihydrodiols. These 
intermediates can be further converted to more reactive diol-epoxides which may 
covalently bind to DNA thus forming bulky adducts (SHIMADA and FUJII-KURIYAMA 
2004).  
 
Figure 1.  Benzo[a]pyrene (B[a]P) 
 
The above-mentioned metabolic pathway of forming DNA adducts via c-PAH diol-
epoxides was thought to be the dominant mechanism of chemical carcinogenesis of 
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c-PAHs until the last decade of the 20
th
 century. However, there have been two more 
fundamental pathways proposed since then (XUE and WARSHAWSKY 2005): 
The second pathway suggests the formation of radical cations of PAHs through one 
electron oxidation catalysed by cytochrome P450 peroxidase activity. In this pathway 
PAHs are oxidised independently of molecular oxygen; organic or lipid hydroperoxides are 
used as the oxidant source instead (ANARI et al. 1995). Radical cations are electrophilic 
and capable of interacting with nucleophilic centres in cellular macromolecules including 
DNA (CAVALIERI and ROGAN 1992). The radical cation mechanism involves 
the formation of unstable adducts primarily at guanine and adenine bases leading to DNA 
damage by depurination. If not repaired, these apurinic sites can lead to mutations in DNA 
(CAVALIERI and ROGAN 1995, XUE and WARSHAWSKY 2005). 
The most recently discovered pathway of PAH metabolic activation involves 
the formation of o-quinones catalysed by dihydrodiol dehydrogenase members of the aldo-
keto reductase superfamily (PENNING et al. 1999). These cytosolic NADP(H)-dependent 
oxidoreductases catalyse the oxidation of PAH trans-dihydrodiols (products of phase I 
metabolic reactions) to PAH o-quinones (SULLIVAN 1985, SMITHGALL et al. 1988, 
BURCZYNSKI et al. 1998). PAH o-quinones are electrophilic metabolites that enter redox 
cycles and generate reactive oxygen species (ROS) (PENNING et al. 1996) thus leading to 
oxidative damage of DNA and other macromolecules (BURCZYNSKI and PENNING 
2000). Formation of ROS and other radicals by PAH o-quinones resulted in increased 
cytotoxicity in rat hepatocytes and the ability of PAH o-quinones to intercalate in DNA 
lead to mutagenic effect in Salmonella typhimurium in the study of FLOWERS-GEARY 
et al. (1996). 
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2.2 Particulate matter (PM) 
The health effects of ambient air pollution have been widely studied over the past few 
decades. Many epidemiological studies have shown an association between exposure to 
particulate air pollution and increases in acute respiratory and cardiovascular diseases 
(SCHWARTZ 1993, 1999, SCHWARTZ and MORRIS 1995, POPE 2000, 
BRUNEKREEF and HOLGATE 2002, BROOK et al. 2004, BRUNEKREEF 2006) and 
increased death rates
 
from lung cancer and cardiopulmonary diseases (DOCKERY et al. 
1993, ABBEY et al. 1999, POPE et al. 2002, BOLDO et al. 2006). In accordance with 
these findings, LADEN et al. (2006) have found a decrease in PM-associated mortality 
consistent with a decrease in concentrations of fine particles in ambient air. 
However, epidemiologic studies face several difficulties: a general problem is 
the assessment of personal exposure, because the relationship between the fixed-site 
measurements and personal exposure may vary from study to study (LIPFERT and 
WYZGA 1995). This problem can be eliminated by using a personal monitoring as 
demonstrated in several cohort studies (SORENSEN et al. 2003, RÖSSNER et al. 2007, 
2008a, 2008b, TOPINKA et al. 2007).  For the cohort studies the difficulty might be 
the choice of the adequate time frame. The major problem is to find an appropriate time 
between exposure to xenobiotics and detectable biological effects. The composition of 
the PM, which varies by the location, may influence its toxicological potency and thus 
results obtained from epidemiological study in one region may not necessarily be consistent 
with results gained elsewhere. Moreover, epidemiology cannot provide definite answers to 
many questions about the causality and mechanisms of the health effect of air pollution 
(ENGLERT 2004). To obtain these answers we need further toxicological in vitro studies. 
Ambient air pollution consists of a variable complex mixture of different chemical 
compounds in the gas, liquid or solid phase. Particulate pollution, also called particulate 
matter (PM), is a mixture of solid and liquid constituents, including inorganic salts such as 
nitrates, sulphates and ammonium, elemental carbon and a large number of organic 
compounds including polycyclic aromatic hydrocarbons (PAHs). Thus, PM includes 
a variety of chemical substances emitted by different sources of air pollution. Particle size 
may range from a few nanometres to tens of micrometres. PM10 and PM2.5 are particles 
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with an aerodynamic diameter of less than 10 and 2.5 µm, respectively. The PM10 fraction 
is also called “respirable particles” and the PM2.5“fine particles”. The particles between 2.5 
and 10 µm are called “coarse particles”. Ultrafine particles (UFPs), also called PM0.1, are 
those with an aerodynamic diameter of less than 0.1 µm. (ENGLERT 2004). PM is further 
classified as primary (originating from many natural and anthropogenic sources and emitted 
directly into the atmosphere) or secondary (formed in the atmosphere by chemical and 
physical transformations and interactions with gases already present in the air). The gases 
mostly involved in the formation of secondary particles are sulphur dioxide (SO2), nitrogen 
oxides (NOx), and ammonia (NH3). Coarse particles are generally primary particles and 
most of them originate from larger particles by crushing or grinding. Main sources of these 
particles include emissions from industrial processes, traffic related emissions including tire 
and paving materials, and grinding of crustal, biological and combustion materials, 
agriculture, mining, fly ash and wind-blown dust. These particles are removed from 
the atmosphere by gravitational settling thus remaining in the air for shorter periods ranging 
from a few hours to a few days (depending on their size, atmospheric conditions and 
altitude). Fine particles are principally generated by combustion processes and 
transformation processes of precursor gases and thus are composed mainly of sulphate, 
nitrate, ammonium, inorganic and organic carbon compounds, and heavy metals such as 
lead and cadmium. This indicates that the origin of fine particles is mostly anthropogenic 
and that this fraction comprises mainly of the secondary particles (US-EPA 1996, WHO 
2004). Furthermore, an important source of the fine particulate pollution in the urban areas 
is fossil fuel combustion by motor vehicles, industry and residential heating. Ultrafine 
particles are formed primarily by the condensation of hot vapours arising during 
combustion processes and by nucleation (gas molecules coming together to form a new 
particle). These extremely small particles coagulate to quickly form larger particles on 
which more vapours condensate making them grow up to the size range of 0.1-2.0 µm. 
These fine particles can be then transported thousands of kilometres and remain in 
the atmosphere for days or weeks depending also on the weather conditions. Ultrafine 
particles themselves remain in the atmosphere very shortly (from minutes to hours) because 
they are very likely to accumulate and form larger particles (US-EPA 1996). 
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The size of the particles not only determines their fate in the atmosphere but also their 
behaviour in the human respiratory tract, including how far the particles penetrate, where 
they deposit, and how successful is their removal from the body. Particles larger than 
10 µm are filtered in the nose and throat and thus do not enter the organism but respirable 
particles (PM10) can reach bronchi and lungs and cause health problems. These adverse 
effects are greater for fine and ultrafine particles because they can penetrate deeper into 
the respiratory tract and within hours after the exposition UFPs can even reach different 
compartments of the body. According to recent studies it is obvious that ultrafine particles 
can translocate to interstitial sites in the respiratory tract as well as to extrapulmonary sites 
such as liver, lymph and blood circulation, and nervous system (OBERDÖRSTER et al. 
2004, ELDER and OBERDÖRSTER 2006, PETERS et al. 2006). Thus, ultrafine particles 
can directly affect cells in various organs inducing oxidative stress and eventually heritable 
mutations (CHOI et al. 2004, SAMET et al. 2004). One of the reasons why particles may 
induce an oxidative burst is the free radical activity of the organic pollutants carried on 
the particles' surface. SQUADRITO et al. (2001) have found out that PM2.5 contains 
quinoid substances that might be responsible for ROS generation by PM2.5 via redox 
cycling mechanism. The reactive oxygen species can then cause oxidative damage to lipids, 
nucleic acids, and proteins at deposition sites within the lungs and in secondary target 
organs. In addition, the particles may induce the release of inflammatory mediators and 
cytokines by the cells. The fine and coarse particles may be phagocytised by macrophages 
and dendritic cells, which can carry the particles to the lymph nodes in the lungs or to those 
closely associated with the lungs, whereas the uptake of ultrafine particles occurs by 
different, non-specific mechanisms (PETERS 2006). GEISER et al. (2005) have studied 
penetration of UFPs into several cell types in vitro (cultured lung macrophages and red 
blood cells) and in vivo (exposure of rats to ultrafine titan dioxide aerosol) and summarised 
that UFPs cross cell membranes by nonphagocytic mechanisms most likely by diffusion. 
OBERDÖRSTER et al. (2004) have shown that inhaled UFPs deposited on the olfactory 
epithelium can be translocated to the brain via the olfactory nerve and therefore exhibit 
neuropathological effects. There have been several studies concerning the problem of 
neurodegenerative consequence of exposure to high levels of ambient particle pollution and 
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a histological evidence of neurodegeneration in both canine and human brains was found 
(CALDERON-GARCIDUENAS et al. 2002, 2003, PETERS 2006). 
 
2.3 Oxidative stress 
Oxidative stress is caused by an imbalance between the production of ROS and 
a biological system's ability to readily detoxify the reactive intermediates or easily repair 
the resulting damage. ROS are either free radicals, reactive anions containing oxygen 
atoms, or molecules containing oxygen atoms that can either produce free radicals or are 
chemically activated by them. Examples are: superoxide anion radical (•O2-), hydroxyl 
radical (•OH), hydrogen peroxide (H2O2), and alkoxy (RO•) and peroxy (ROO•) organic 
radicals. In living cells these reactive molecules are formed continuously as a consequence 
of metabolic reactions. The main source of ROS in the organism is oxidative 
phosphorylation in mitochondria, though ROS are also produced by oxidative burst 
in leukocytes, by peroxisomal beta oxidation of fatty acids or microsomal cytochrome P450 
metabolism of xenobiotic compounds (SCHOLZ et al. 1990). ROS can be beneficial, 
as they are used by the immune system as a way to attack and kill pathogens, and are also 
involved in cell signalling where they act as second messengers (FORMAN et al. 2004). 
However, the excessive generation of ROS can lead to the damage of lipids, proteins and 
nucleic acids. This damage, if unrepaired, accumulates and leads to the physiological 
attrition and an increased risk of several acute and chronic diseases including cancer, 
cardiovascular, neurodegenerative or lung diseases (MONTUSCHI et al. 2004, HWANG 
and KIM 2007). 
Under normal physiological conditions, cells are able to defend themselves against 
ROS damage through the use of enzymes such as superoxide dismutase (SOD), catalase, 
glutathione peroxidase (GPx), and glutathione-S-transferase (GST). Small molecule 
antioxidants such as ascorbic acid (vitamin C), tocopherol (vitamin E), uric acid, and 
glutathione also play important roles as cellular antioxidants. 
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2.3.1 Antioxidant enzyme system 
Superoxide dismutase 
 SODs are a class of enzymes that catalyse the dismutation of two superoxide 
radicals into hydrogen peroxide and oxygen: 
2 •O2- → H2O2 + O2  (SOD) 
 In humans, as well as in all other mammals, three forms of superoxide dismutase are 
present: SOD1 is located in the cytoplasm, consists of two subunits each containing one 
copper and one zinc atoms. SOD2 is located in the mitochondria, consists of four subunits 
and has manganese in its reactive centre. SOD3 is an extracellular superoxide dismutase 
isoform consisting of four subunits each containing one copper and one zinc atoms. 
Catalase 
 Catalase is a common enzyme found in nearly all living organisms which are 
exposed to oxygen. It catalyses the decomposition of hydrogen peroxide to water and 
oxygen: 
2 H2O2 → 2 H2O + O2 (catalase) 
 Catalase, present predominantly in peroxisomes, is a tetramer containing four 
porphyrin haem (iron) groups in the active site. It is an enzyme with one of the highest 
turnover; one molecule of catalase can convert millions of molecules of hydrogen peroxide 
to water and oxygen per second. 
Glutathione peroxidase 
 GPx is a selenium-containing enzyme. It reduces hydrogen peroxide to water by 
transferring reactive electrons from peroxide to glutathione (GSH) which is thus converted 
to its oxidised form, glutathione disulfide (GSSG): 
H2O2 + 2 GSH → GS–SG + 2H2O (GPx) 
 There are four forms of glutathione peroxidase enzymes: 
1) cytosolic glutathione peroxidase (cGPx) – ubiquitously distributed 
2) phospholipid-hydroperoxide glutathione peroxidase (PHGPx) – located in plasma 
membranes to reduce hydroperoxides of lipids 
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3) plasma glutathione peroxidase (pGPx) – located in blood plasma 
4) gastro-intestinal glutathione peroxidase (giGPx) – located in liver and 
gastrointestinal tract  
cGPx, pGPX and giGPx are tetramers, while PHGPx is a monomer. 
Glutathione S-transferase 
 The mammalian GST family consists of cytosolic dimeric isoenzymes catalysing 
the conjugation of reduced glutathione to electrophilic centres of a wide variety of 
substrates. This activity detoxifies endogenous compounds such as peroxidised lipids 
as well as many different xenobiotic metabolites.  
 
2.3.2 Oxidative DNA damage 
 Oxidative damage to DNA is a result of interaction of DNA with ROS, in particular 
the hydroxyl radical. The hydroxyl radical produces a multiplicity of modifications 
in DNA, such as single base and sugar-phosphate damage, as well as strand breaks. One of 
the major types of DNA damage generated by ROS is formation of apurinic sites. 
In addition to this lesion, a wide spectrum of oxidative base modifications occurs by ROS 
activity (Figure 2.). The C4-C5 double bond of pyrimidine is particularly sensitive to attack 
by hydroxyl radical, generating a spectrum of oxidative pyrimidine damage including 
thymine glycol, uracil glycol, 5-oxodeoxyuridine, 5-oxodeoxycytidine and others. 
Similarly, interactions of hydroxyl radical with purines generate 8-oxodeoxyguanosine 
(8-oxodG), 8-oxodeoxyadenosine, formamidopyrimidines and other oxidative products 
(KOW and DARE 2000, LOFT et al. 2008). 
 Among all purine and pyrimidine bases, guanine is the one most prone to oxidation. 
Guanine base is oxidised in the position 8 and the result of this modification, 8-oxodG, is 
one of the predominant forms of free radical-induced lesions to DNA. 8-oxodG is by far 
the most studied oxidative DNA lesion and has gained much attention, because it is highly 
mutagenic in bacterial and mammalian cells (CHENG et al. 1992, MORIYA and 
GROLLMAN 1993). The oxidised guanine residue can pair both with cytosine and 
adenine, and if not repaired, its presence may result in G:C→T:A transversions (MORIYA 
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1993, LE PAGE et al. 1995).  Thus, oxidative DNA damage may be implicated in cancer 
risk (RISOM et al. 2005). 
 The most frequently used methods of 8-oxodG analysis include high-performance 
liquid chromatography (HPLC) with electrochemical detection, single-cell gel 
electrophoresis (SCGE) and the competitive ELISA (CHIOU et al. 2003, LOFT et al. 
2008). 
 
 
 
 
 
                             5-OHdU   5-OHdC       Thymine glycol 
 
 
 
 
    Uracil glycol  8-oxodA  8-oxodG 
 
 
       Fapy-dA           Fapy-dG 
Figure 2. Chemical structures of some of the stable oxidative DNA base lesions (according to LOFT et al. 
2008, modified) 
5-OHdU = 5-hydroxydeoxyuracil; 5-OHdC = 5-hydroxydeoxycytosine; 8-oxodA = 8-oxodeoxyadenine; 
8-oxodG = 8-oxodeoxyguanine; Fapy-dA = 4,6-diamino-5-formamidopyrimidine; Fapy-dG = 2,6-diamino-
4-oxo-5-formamidopyrimidine  
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2.3.3 Lipid peroxidation 
 After being attacked by ROS, lipids are peroxidised, forming reactive intermediates 
that may further react with other molecules and propagate oxidative stress (MONTUSCHI 
et al. 2004). Apart from this process, oxidised lipids also change the properties of 
the cellular membranes, including their fluidity and the inactivation of membrane-bound 
proteins. As a result, normal cellular functions are impaired. Oxidised lipids are degraded to 
a wide variety of products as short chain alkanes, aldehydes, alkenyls, isoprostanes and 
others (DE ZWART et al. 1999). 
 To monitor lipid peroxidation in vivo, several biomarkers have been proposed. 
Traditionally, measurement of malondialdehyde (MDA) using a reaction with thiobarbituric 
acid (TBA) has been widely used as a marker of lipid peroxidation (GUTTERIDGE and 
HALLIWELL 1990). Unfortunately, the TBA assay was proved to be non-specific for 
MDA as TBA is also reactive with other compounds that may be present in biological 
samples (HALLIWELL et al. 2000, KORCHAZHKINA et al. 2003). Since isoprostanes 
were described to be formed in vivo in humans almost two decades ago (MORROW et al. 
1990), they have become the most reliable marker of lipid peroxidation that was proved to 
be associated with oxidative damage in a number of human diseases (ROBERTS and 
MORROW 2000). Isoprostanes are prostaglandin-like compounds formed by a non-
enzymatic peroxidation of arachidonic acid. They include several groups, but 
F2-isoprostanes, particularly the 15-F2t-isoprostane isomer (15-F2t-IsoP, also called 
8-isoprostane), are the best characterised and most often studied compounds (NOUROOZ-
ZADEH 2008). 
 
2.3.4 Protein oxidation 
 Because proteins are major components of most biological systems, they are 
an important target for ROS, scavenging 50-75% of reactive intermediates (DALLE-
DONNE et al. 2006a). Protein oxidation leads to the formation of a number of products, 
with protein carbonyls being the best characterised (HWANG and KIM 2007). Protein 
carbonylation is an irreversible, non-enzymatic process that results in the introduction of 
carbonyl groups into protein molecules in various ways. Proteins can react either directly 
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with ROS or indirectly via a reaction with other oxidised macromolecules (lipids or sugars). 
Direct oxidation results in the formation of oxidation products on the side chains of 
the amino acids lysine, arginine, proline and threonine, in the oxidation of glutamyl 
residues, or in the cleavage of peptide bonds (DALLE-DONNE et al. 2006a). Indirect 
oxidation includes the reaction of a protein molecule with oxidised lipids (such as MDA or 
4-hydroxynonenal) or with the oxidation products of sugars. The oxidation of proteins 
results in changes in their conformation leading to their partial or total inactivation 
(STADTMAN and LEVINE 2003), their failure to fold correctly (DALLE-DONNE et al. 
2006a), or, in the case of heavy oxidation, to proteolysis (GRUNE et al. 2004). Protein 
oxidation has been linked with the progression of various diseases, although in many cases 
it remains unclear whether protein oxidation is the cause or the consequence of a particular 
illness (DALLE-DONNE et al. 2006b). At present, the analysis of protein carbonyl levels 
by ELISA is considered the most sensitive measurement of protein oxidation 
(SHACTER 2000). 
 
2.4 PAHs and oxidative stress 
 Several studies were concerning the influence of PAHs, especially B[a]P, on 
the induction of oxidative stress in vivo and in vitro.  
 KIM and LEE (1997) investigated the induction of oxidative damage to DNA and 
proteins and activities of antioxidant enzymes SOD and catalase in target organs of rats 
following oral exposure to B[a]P. Levels of 8-oxodG, carbonyl content of proteins and 
activity of SOD and catalase were determined in liver, kidney and lung tissues at different 
time points. The results showed that B[a]P was able to cause oxidative damage to DNA and 
proteins and to decrease the activity of antioxidant enzymes SOD and catalase.  
 Similarly, GARCON et al. (2001a) determined oxidative stress induced in the lungs 
of rats exposed to hematite (Fe2O3), B[a]P or B[a]P coated onto Fe2O3 particles. 
As markers of oxidative stress, levels of MDA and 8-oxodG and activities of antioxidant 
enzymes SOD, GPx and GR were determined. The results showed increase in MDA 
production in all exposed animals and increased levels of 8-oxodG in lung tissue biopsies 
of rats treated with B[a]P or B[a]P coated onto Fe2O3 particles. SOD activity decreased 
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following the treatment in all exposed animals while other enzyme activities remained 
unaltered. The main finding of this work was that B[a]P coated onto Fe2O3 particles caused 
approximately ten times higher oxidative damage to the lungs than B[a]P alone. 
 A similar study was conducted by the same authors (GARCON et al. 2001b) but 
in vitro on human lung adenocarcinoma cell line (A549). The cells were incubated with 
Fe2O3, B[a]P, pyrene, B[a]P coated onto Fe2O3 particles or pyrene coated onto Fe2O3 
particles. However, exposure to B[a]P did not result in increases in lipid peroxidation 
measured as the MDA production. This effect was restricted only to cells treated with 
B[a]P coated onto Fe2O3 particles or pyrene coated onto Fe2O3 particles.  
 PARK et al. (2006) investigated the potential of B[a]P to induce oxidative stress-
related DNA damage and p53 modification in HepG2 cells. Exposure to B[a]P induced 
a decrease in cell viability, but increased the antioxidant enzyme activity as well as lipid 
peroxidation and non-specific DNA damage. 
In the study of GÁBELOVÁ et al. (2007) the induction of oxidative DNA damage 
by B[a]P was determined in HepG2 cells by a modified SCGE with the use of a repair-
specific DNA endonuclease (formamidopyrimidine-DNA glycosylase, Fpg). However, the 
results of this study do not show any increase in oxidative base modifications following 
exposure to B[a]P. 
 Generally, the results of above-mentioned studies do not show any clear conclusion 
about the oxidative stress induction by B[a]P.  
 
2.5 Particulate matter and oxidative stress 
 To investigate the mechanism of oxidative stress induction by particulate matter, 
numerous in vivo as well as in vitro studies have been conducted in recent years. In these 
projects different types of particles were used: from diesel exhaust particles (the most often 
used ones in in vivo studies) to urban air particles of different size and composition. It is 
also important to mention that in in vitro studies the solvents, in which the particles are 
suspended, vary. For in vivo studies, modes of particle administration vary with inhalation 
and intratracheal instillation being used most often. Other differences involve various 
markers of oxidative stress and different methods of their analysis. Despite these 
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differences, the results in general indicate that the particles induce oxidative stress (RISOM 
et al. 2005). 
 
2.5.1 Particulate matter and oxidative DNA damage in vivo  
2.5.1.1 Model studies in animals and humans 
 Respiratory tract toxicity of air pollution particles has been extensively studied over 
the years but the focus on the DNA oxidation in the lungs is only since the mid- 1990s 
(MOLLER et al. 2008). Though a large variety of PM is available, most of the in vivo 
studies use diesel exhaust particles (DEP). DEP are present in urban air pollution, however 
the composition of DEP and total urban PM can be fairly distinct. 
 NAGASHIMA et al. (1995) investigated the formation of 8-oxodG in the lung 
DNA of mice after an intratracheal instillation of DEP. The influence of high dietary fat 
and beta-carotene on the oxidative DNA damage formation was also examined. The results 
showed a bell-shaped induction of 8-oxodG in lung tissue with the peak effect twelve hours 
after the administration and the dose of 0.2-0.3 mg having the highest effect. High dietary 
fat enhanced the formation of 8-oxodG while the intake of beta-carotene had the opposite 
effect.  
 Similar results were obtained by ICHINOSE et al. (1997), who examined 
the relationship between the formation of 8-oxodG in lung tissue of mice and lung tumour 
response. Mice were intratracheally injected with different concentrations of DEP once 
a week for ten weeks. After ten weeks, the inflammatory reaction was observed 
in the respiratory tract and after twelve months, the lung tumour incidence was increased 
in treated mice. The 8-oxodG levels in treated mice showed a dose-dependent increase. 
The formation of 8-oxodG was enhanced by high dietary fat and was also significantly 
correlated with the lung tumour incidence. Beta-carotene partially reduced the 8-oxodG 
formation and the development of benign and malignant tumours induced by 
the combination of high dietary fat and exposure to DEP.  
 TSURUDOME et al. (1999) studied the levels of 8-oxodG and the induction of 
the specific repair enzyme transcription (OGG1) in the lungs of rats after a single 
instillation of DEP. The highest levels of 8-oxodG were observed 2 hours after exposure to 
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4 mg DEP and were decreasing gradually until they reached control levels the fifth day 
after the treatment. OGG1 gene transcription was strongly induced in rats treated with 4 mg 
of DEP five to seven days after the administration.  
 Another study of rats exposed to DEP by inhalation was conducted by IWAI et al. 
(2000). The results of this study showed a gradual increase in 8-oxodG following 
the duration of repeated exposures to DEP, and the development of lung cancer in treated 
animals.  
 Similar results obtained MOLLER et al. (2003) in their study on guinea pigs. 
The animals were exposed to DEP by intratracheal instillation. Five days later, increased 
levels of oxidised amino acid marker (gamma-glutamyl semialdehyde), DNA strand breaks, 
and 8-oxodG in treated guinea pigs were observed. Moreover, the activity of glutathione 
reductase (GR) was increased while activities of other antioxidant enzymes GPx and SOD 
remained unaltered. 
 BRÄUNER et al. (2007) investigated oxidative DNA damage in peripheral blood 
mononuclear cells in humans during controlled exposure to ultrafine urban air particles. 
The levels of strand breaks and oxidised bases were measured by the SCGE with Fpg. In 
this assay, Fpg removes oxidised purine bases (primarily guanine) and introduces breaks in 
the DNA. The results of the study show that UFPs, especially the fraction with a median 
diameter of 57 nm, was associated with oxidative stress. 
 A conclusion that can be made from the data obtained from in vivo studies is that 
exposures to DEP or urban UFPs are associated with elevated levels of oxidative DNA 
damage and with increased cancer risk (RISOM et al. 2005, MOLLER et al. 2008).     
 
2.5.1.2 Human biomonitoring studies 
As oxidative stress is believed to be one of the major sources of PM-mediated 
adverse health effects, there have been also several human biomonitoring studies conducted 
over the last decade, which were concerning PM and oxidative stress. In these studies 
positive correlations between the PM exposure and oxidative stress markers were observed.  
 LOFT et al. (1999) have found increased excretion of urinary 8-oxodG in a group 
with higher exposure to ambient air pollution (bus drivers from central Copenhagen) as 
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compared with a group with lower exposure (drivers from rural/suburban greater 
Copenhagen).  
 Similarly, CHUANG et al. (2003) have seen significantly elevated marker of 
oxidative DNA damage (urinary 8-oxodG) in an exposed group of city taxi drivers in 
Taipei compared to a reference group of men from the residential community with 
the lowest levels of air pollution in the city of Taipei.  
 SORENSEN et al. (2003) studied the influence of personal PM2.5 exposure on 
the levels of DNA damage in 50 students living and studying in Copenhagen. The results of 
this study indicate that personal exposure to PM2.5 was a predictor of 8-oxodG levels in 
lymphocyte DNA.   
 In accordance with these findings, RÖSSNER et al. (2007) have observed 
significantly increased levels of oxidative stress markers (8-oxodG, protein carbonyls and 
15-F2t-IsoP) in 50 bus drivers from Prague when compared to controls (a group of 
administrative workers). 
 The results of above-mentioned studies suggest that exposure to ambient air 
pollution causes oxidative damage to humans. However, most of these studies encompass 
only particle size and concentration. They do not elucidate the importance of different 
chemical fractions of PM, nor do they clarify the mechanism of the oxidative stress 
induction by ambient air pollution.  
 
2.5.2 Particulate matter and oxidative stress in vitro  
 SHI et al. (2003) determined the induction of 8-oxodG by PM in aqueous 
suspension in a cell-free system (calf thymus DNA) and in A549 cells. The results showed 
that PM was able to induce 8-oxodG in CT DNA as well as in A549 cells.  
 Similarly PRAHALAD et al. (2001) tested the induction of 8-oxodG by many 
different types of ambient particles in cell free systems – free deoxyguanosine and CT 
DNA – and in human epithelial cells. The levels of induced 8-oxodG depended on the type 
and composition of particles: generally, damage was affected by the concentration of water-
soluble contents of particles. 
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 Another in vitro study was conducted by GARCON et al. (2006) determining 
oxidative stress caused by Dunkerque city air pollution in human epithelial lung cells 
(L132) in culture. The results show concentration and time-dependent increases in MDA 
and 8-oxodG levels following PM exposure. 
 The study of GÁBELOVÁ et al. (2007) was aimed at determining the impact of 
the EOM from airborne particles on oxidative damage to DNA in HepG2 cells. The levels 
of 8-oxodG were analysed using a modified SCGE with Fpg. From the eight EOM tested, 
only one induced significant increase in oxidative DNA lesions in three from total six 
concentrations applied. 
 Contrary to the study of GÁBELOVÁ et al. (2007), LAZAROVÁ and 
SLAMEŇOVÁ (2004) found a significant increase in oxidative DNA damage in HepG2 
cells after the treatment with all tested concentrations of two different EOM samples using 
also a modified SCGE.  
 Though using different fractions of PM originating from different sources and using 
distinct methods of oxidative stress detection, the results of in vitro studies in general show 
some positive effect of PM on oxidative stress induction. 
 
2.6 Cell lines 
Two cell lines were used in the study: the human hepatoma cells (HepG2) and human 
diploid lung fibroblasts (HEL). The HepG2 cells retain many characteristic enzyme 
pathways of human hepatocytes, they are easily available, and it is possible to passage them 
more than hundred times (SILVERS et al. 1994). In contrast, primary human hepatocytes, 
regarded as a “gold standard” in toxicology, are not easily available because of the shortage 
of human livers needed for hepatocyte isolation. HepG2 cells contain PAH-inducible 
CYP1A1 enzyme (BURCZYNSKI et al. 1999, VAKHARIA et al. 2001, WU et al. 2003) 
and their overall xenobiotic metabolising capacity is comparable to that of human 
hepatocytes in primary culture (IBA et al. 2002). HepG2 cells are able to activate PAHs to 
DNA reactive metabolites (DIAMOND et al. 1980). They are considered a good model for 
in vitro testing of individual PAHs, their artificial mixtures as well as organic extracts from 
ambient air particles (SEVASTYANOVA et al. 2007). However, toxicogenomic studies 
30 
 
(HARRIS et al. 2004) indicated that though expressing similar genes to human liver and 
primary cultured hepatocytes, HepG2 cells also express a significant number of other 
genes, not found in human hepatocytes and probably related to a transformed phenotype. 
When compared to HepG2 cells, human diploid lung fibroblasts at confluency are closer to 
in vivo conditions, since tumour cell lines may contain many mutations which may affect 
the DNA damage response (DI LEONARDO et al. 1994, VENKATACHALAM et al. 
1997).  
According to SEVASTYANOVA et al. (2007), HepG2 cells represent 
a metabolically competent system for activating c-PAHs as well as EOM in a wide range of 
concentrations while confluent cultures of HEL cells represent a relevant in vitro model of 
lung tissue as a major target for air pollutants, suitable for testing individual PAHs but with 
reduced capacity of metabolising the artificial c-PAH mixtures and real EOM. 
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3 MATERIALS AND METHODS 
3.1 Chemicals, biochemicals and solutions 
3.1.1 Cultivation media and cell treatment solutions  
William's medium E without L-glutamine - (Gibco, Invitrogen, USA) 
Eagle's minimal essential medium (E-MEM) - (Sevapharma, Czech Republic)  
Foetal bovine serum (FBS) - (Biochrom AG, Germany) 
Glutamine – (Sevapharma, Czech Republic) 
Penicillin – (Biotika, Slovakia) 
Sodium Bicarbonate – (7.5% solution, Biochrom AG, Germany) 
Trypsin - (0.25% solution with 1mM EDTA, without calcium and magnesium, MP 
Biomedicals, USA) 
Phosphate-buffered saline (PBS)  
for 500 ml: 
4 g NaCl, 0.58 g Na2HPO4, 0.1 g KH2PO4, 0.1 g KCl 
volume adjusted to 500 ml with dH2O  
 
3.1.2 Chemicals and solutions 
c-PAHs: benz[a]anthracene (B[a]A), benzo[a]pyrene (B[a]P), benzo[b]fluoranthene 
(B[b]F), benzo[k]fluoranthene (B[k]F), benzo[g,h,i]perylene (B[g,h,i]P), chrysene 
(CHRY), dibenz[a,h]anthracene (DB[a,h]A), dibenzo[a,l]pyrene (DB[a,l]P), 
indeno[1,2,3-c,d]pyrene (I[1,2,3-c,d]P) – (Sigma-Aldrich, USA) 
Dimethyl sulfoxide - (Sigma-Aldrich, USA) 
CelLytic reagent - (Sigma-Aldrich, USA) 
Bicinchoninic acid - (Sigma-Aldrich, USA) 
Copper (II) sulphate solution (CuSO4·5 H2O) - (Sigma-Aldrich, USA), 4% solution of 
Copper (II) sulphate pentahydrate 
Tween 20 (Polyoxyethylene sorbitan monolaurate) - (Sigma-Aldrich, USA) 
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Bovine serum albumin (BSA) - (Sigma-Aldrich, USA) 
Ribonuclease A - (Sigma-Aldrich, USA) 
Ribonuclease T1 - (5000 U/ml, Sigma-Aldrich, USA) 
Proteinase K - (Sigma-Aldrich, USA)  
 
Other chemicals not listed in this section were obtained from Sigma-Aldrich, USA.  
 
Solutions for DNA isolation: 
Deferoxamine mesylate (DFA) 0.1 mM 
for 100 ml: 
6.6 mg DFA in 100 ml dH2O 
50 mM Tris 
1.21 g Trizma-base in 200 ml 0.1 mM DFA 
pH adjusted to 7.4 with HCl  
Extraction buffer  
for 1 l: 
2.42 g Trizma-base, 3.72 g EDTA, 10.0 g Sodiumdodecylsulphate (SDS), 66 mg 
DFA, 1000 ml dH2O 
 
RNAse mix 
10 mg Ribonuclease A, 1 ml 50 mM Tris 
Mixed and incubated 10 minutes at 80 °C, then cooled down, pipetted into a vial of 
Ribonuclease T1 (5000 U/ml), mixed gently and stored  at –20 °C. 
 
Proteinase K (concentration 40 U/mg) 
 10 mg/ml 0.1mM DFA  
 
 5M NaCl + DFA 
 29.23 g NaCl in 100 ml 0.1mM DFA 
33 
 
 CI + antioxidant 
240 ml chloroform, 10 ml 3-methyl-1-butanol, 80 ml of 50 mM Tris 
 
Solutions for ELISA 
 8-oxodG ELISA 
 PBS pH 7.4  
for 1000 ml: 
8g NaCl, 0.2 g KCl, 1.42 g Na2HPO4, 0.24 g KH2PO4 
volume adjusted to 1000 ml with dH2O  
pH adjusted with HCl  
Wash buffer 
for 1000 ml: 
2 ml 10% NaN3, 0.5 ml Tween 20 in 997.5 ml PBS pH 7.4 
 
Blocking buffer - 1% FBS in PBS/Tween    
for 100ml: 
1 ml FBS, 50 μl Tween 20 in 99 ml PBS 
 
 8-oxodG standard – (Sigma-Aldrich, USA) 
 Primary antibody N45.1 – (JaICA, Japan)   
 Secondary antibody – anti-mouse IgG, alkaline phosphatase conjugated – (Sigma-
 Aldrich, USA) 
 Phosphatase substrate – 5 mg/tablet (Sigma-Aldrich, USA) 
 
 15-F2t-isoprostane ELISA 
8-Isoprostane EIA Kit – (Cayman Chemical Company, USA) 
EIA Buffer, Wash Buffer, 8-Isoprostane Standard (50 ng/ml), 
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8-Isoprostane AChE Tracer, 8-Isoprostane Antiserum, 
Ellman’s Reagent (substrate) – acetylthiocholine and 5,5’ – dithio – 
bis-(2-nitrobenzoic acid) 
 
Isoprostane Affinity Sorbent – (Cayman Chemical Company, USA) 
Potassium hydroxide (KOH) - (Sigma-Aldrich, USA)  
Elution solution – 95% ethanol in dH2O (Sigma-Aldrich, USA) 
1M potassium phosphate:  
for 1000 ml:  
136.09 g KH2PO4 volume adjusted to 1000 ml with dH2O  
Column buffer  
for 1000 ml: 
13.6 g KH2PO4, 29.23 g NaCl, 0.5 g NaN3  
volume adjusted to 1000 ml with dH2O  
 
 Carbonyl ELISA 
Coating buffer – 10mM sodium phosphate buffer in 140 mM NaCl (PBS) – 
pH 7.0 
for 1000 ml: 
1.42 g  Na2HPO4, 8.19 g  NaCl in 1000 ml dH2O  
pH adjusted to 7.0 with HCl 
Blocking buffer - 0.1% BSA in PBS    
100 mg BSA in 100 ml Coating buffer 
0.1% BSA, 0.1% Tween 20 in PBS    
100 mg BSA, 100 μl Tween 20 in 100 ml Coating buffer 
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Derivatisation solution – 10 mM 2,4- Dinitrophenylhydrazine (DNPH), 6.0M 
Guanidine Hydrochloride, 0.5M Potassium Phosphate, pH 2.5 
for 100 ml: 
198 mg 2,4-DNPH in 3.33 ml concentrated phosphoric acid (85%) 
57.32 g guanidine hydrochloride in 25 ml dH2O 
pH adjusted to 2.5 with 10M KOH 
volume adjusted to 100 ml with dH2O  
PBS pH 7.4 
for 1000 ml: 
8 g NaCl, 0.2 g KCl, 1.42 g Na2HPO4, 0.24 g KH2PO4 
pH adjusted to 7.4 with HCl  
volume adjusted to 1000 ml with dH2O  
Wash buffer 
for 1000 ml: 
2 ml 10% NaN3, 0.5 ml Tween 20 in 997.5 ml PBS pH 7.4 
2M Tris base  
for 100 ml:  
24.2 g in 100 ml dH2O 
2.5M sulphuric acid 
for 100ml:  
2.68 ml H2SO4 (98%) in 97.32 ml dH2O  
primary antibody – biotinylated anti-dinitrophenyl-keyhole limpet hemocyanin 
conjugate (anti-DNP-KLH) – (Molecular Probes, USA) 
streptavidin-biotinylated horseradish peroxidase conjugate – (GE Healthcare, 
UK) 
3,3’, 5,5’ - tetramethylbenzidine substrate (TMB) – (Sigma-Aldrich, USA) 
 
LDH - cytotoxicity assay kit II – (BioVision, USA)  
 WST Substrate Mix, LDH Assay Buffer, Cell lysis solution, LDH (0.1 µg/ml) 
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3.2 Air sampling, organic matter extraction and chemical analysis 
Airborne particles of an aerodynamic diameter < 10 µm (PM10) were collected in 
the centre of Prague (Smíchov) 24 hours a day in three different periods: in summer 2000 
(June 15
th
 2000 – September 15th 2000), in winter 2001 (December 4th 2000 – March 3rd 
2001) and in winter 2005 (November 7
th
 2005 – December 22nd 2005) using HiVol (high 
volume) air samplers (Anderson, USA) with 20x30 cm Pallflex filters (T60A20). EOM was 
obtained from the filters by dichloromethane extraction. Extracts were divided into two 
equal parts. The first was used for chemical analysis and the second for in vitro testing. 
Quantitative chemical analysis of PAHs was performed in the certified laboratory ALS 
Czech Republic (ISO 17025).  
The concentrations of eight PAHs classified by International Agency for Research 
on Cancer (IARC, in preparation) as c-PAHs, including B[a]A, CHRY, B[b]F, B[k]F, 
B[a]P, DB[a,h]A, B[g,h,i]P, and I[1,2,3-c,d]P were analysed in each EOM sample. 
Individual c-PAH content in EOM from the three periods is summarised in Table 1. For the 
in vitro experiments, the EOM samples were evaporated to dryness under a stream of 
nitrogen and re-dissolved in dimethyl sulfoxide (DMSO) to a concentration of 50 mg/ml.  
Table 1. c-PAHs in the EOM extracted from respirable air particles collected in Prague during three different 
periods (according to SEVASTYNOVA et al. 2008, modified) 
Compound 
Summer 2000 
ng/mg EOM 
Winter 2001 
ng/mg EOM 
Winter 2005 
ng/mg EOM 
Benz[a]anthracene 34 348 478 
Chrysene 39 315 687 
Benzo[b]fluoranthene 74 308 299 
Benzo[k]fluoranthene 36 134 224 
Benzo[a]pyrene 50 234 493 
Dibenz[a,h]anthracene 10 19 40 
Benzo[g,h,i]perylene 132 127 343 
Indeno[1,2,3-c,d]pyrene 87 167 343 
Total c-PAHs 462 1654 2906 
c-PAHs – carcinogenic polycyclic aromatic hydrocarbons 
EOM – organic extracts from respirable air particles  
37 
 
3.3 Artificial mixture of c-PAHs (c-PAH mix) 
 The artificial mixture of c-PAHs was prepared in the Department of Genetic 
Ecotoxicology, Institute of Experimental Medicine, v.v.i., Prague, according to the 
chemical analysis of c-PAHs in EOM obtained in Prague during the sampling period of 
winter 2001. The concentration of B[a]P was used as a basis and the concentrations of other 
components were calculated according to the relative abundance of other c-PAHs as 
detected in real EOM (Table 2.). 
Table 2. Proportion of individual c-PAHs in the c-PAH mix 
Compound 
 
% 
Benz[a]anthracene 21.1 
Chrysene 19.0 
Benzo[b]fluoranthene 18.6 
Benzo[k]fluoranthene 8.1 
Benzo[a]pyrene 14.2 
Dibenzo[a,h]anthracene 1.2 
Benzo[g,h,i]perylene 7.7 
Indeno[1,2,3-c,d]pyrene 10.1 
c-PAHs –carcinogenic polycyclic aromatic hydrocarbons 
 c-PAH mix – an artificial mixture of c-PAHs 
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3.4 Cell culture conditions and treatment  
3.4.1 HepG2 cells 
 The human HepG2 cell line, derived from a primary hepatoblastoma isolated from 
an 11-year-old Argentinean male (ADEN et al. 1979), was kindly provided by A. Gábelová 
(Cancer Research Institute, Bratislava, Slovakia).  
 The HepG2 cells were cultivated in 75 cm
2 
flasks in William's medium containing 
10% FBS, 2 mmol/l glutamine and 50 U/ml penicillin, at 37 °C and 5% CO2. The cells were 
seeded in the plastic cell culture flasks (75 cm
2
) at an initial concentration of ~ 25,000 
cells/cm
2
. The macrophotograph of the growing cells is shown in Figure 3. (magnification 
200x).  
 
 
 
Figure 3. HepG2 cells in culture. 
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3.4.2 HEL cells 
Human embryonic lung diploid fibroblasts (HEL Sevapharma, Czech Republic) 
were grown in minimal essential medium E-MEM supplemented with 10% FBS, 
0.2% sodium bicarbonate and 100 U/ml penicillin (Figure 4., magnification 200x). Cells 
were seeded in the plastic cell culture flasks (75 cm
2
) at an initial concentration 
of ~ 17,000 cells/cm
2
 and incubated at 37 °C in 5% CO2. 
 
 
Figure 4. HEL cells in culture. 
 
 
3.4.3 Cell passaging 
Both cell lines are adherent. When the cells reached about 70% confluency, usually 
three or four days after passaging for HepG2 and seven days for HEL cells, the medium 
was removed, the cells were washed with PBS. Then 1.5 ml of trypsin solution was added 
to detach the cells from the bottom of the flask. After 5 minutes of incubating at 37 ºC the 
enzymatic reaction was stopped by adding 8.5 ml of medium, containing 10% FBS. The 
cells were resuspended in the medium and counted in the Bürker chamber. 2-3 millions of 
HepG2 and 1.25-1.5 millions of HEL cells were seeded per flask and supplied with fresh 
medium.  
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3.4.4 Cell treatment with c-PAHs and EOM 
The cells were cultivated in the medium with 10% FBS until confluence. Before the 
cell treatment, the medium was replaced with fresh medium supplemented with 1% bovine 
serum. Individual c-PAHs (B[a]P, DB[a,l]P), the c-PAH mix and EOM were diluted in 
DMSO. The confluent cells were exposed for 24 or 48 hours to different concentrations of 
the compounds and mixtures. All chemicals and concentrations used for the treatment are 
summarised in Table 3. Cells incubated with individual c-PAHs, their artificial mixture and 
EOM were analysed in triplicates in at least two independent experiments. Every 
experiment included negative controls with DMSO only. After exposure, the medium was 
removed and the cells washed twice with PBS. Then the cells were harvested by scraping. 
Each flask of HepG2 or HEL cells was harvested into a 15 ml centrifugation tube with 4 ml 
of PBS and centrifuged for 5 min at 800g. Cell pellets were washed twice with 13 ml of 
PBS.  
Finally the cells were resuspended in 5 ml of PBS. 1 ml of suspension from each 
sample was transferred to a 1.5 ml tube, supernatant was aspirated and cells stored at -80 ºC 
for future preparation of the cell lysates. The remaining cell suspension (4 ml) was 
processed and frozen separately and used for DNA isolation. 
 
Table 3. Tested compounds  
Compound Concentration Unit  
Benzo[a]pyrene 1, 10, 100 µM 
Dibenzo[a,l]pyrene 0.1, 0.5 µM 
c-PAH mix* 5, 50  µM B[a]P** 
EOM Summer 2000  10, 25, 50 µg/ml 
EOM Winter 2001 10, 25, 50 µg/ml 
EOM Winter 2005 10, 25 µg/ml 
B[a]P - benzo[a]pyrene; c-PAHs – carcinogenic polycyclic aromatic hydrocarbons 
EOM – organic extracts from respirable air particles 
* c-PAH mixture was prepared on the basis of chemical analysis of c-PAHs in 
EOM extracted from respirable air particles collected in Prague in the winter 
period 2001 as described in the chapter 3.3 
** the abundance of each individual c-PAH in the mixture was calculated in 
relation to the B[a]P content and is shown in Table 2.   
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3.4.5 Cytotoxicity assay 
 Cytotoxicity of the tested compounds was scored using the LDH-cytotoxicity test 
based on a lactate dehydrogenase (LDH) release from cells following damage to their 
plasma membranes. LDH released from damaged cells oxidises lactate to generate NADH, 
which then reacts with the substrate mix (WST-1) to generate yellow colour. The intensity 
of the generated colour correlates directly with the number of cells lysed. 
 The suspensions of HepG2 and HEL cells in fresh medium with 1% FBS were 
seeded in a 96-well flat-bottomed tissue culture plate (Corning, USA). 100 µl of the cell 
suspension (containing 6 x 10
4
 of HepG2 cells or 4 x 10
4
 of HEL cells) was seeded per well 
in triplicates. Then the tested compounds were added and the plates were incubated for 
an adequate time (24 or 48 hours) in an incubator at 37°C and 5% CO2. 100 µl of 
the culture medium with no cells in triplicate was used as a blank and 100 µl of the cell 
suspension without any compounds in triplicate was used as a low control. The high control 
was established by adding 10 µl of cell lysis solution to the triplicate wells with the cells 
only (no tested compounds) 30 minutes before the end of the incubation. At the end of 
the incubation, the plate was gently shaken and centrifuged at 250 g for 10 minutes. 
Subsequently the clear media (10 µl per well) were transferred into the corresponding wells 
of another 96-well plate and 100 µl of LDH reaction mix was added (200 µl of WST 
substrate mix in 5 ml of LDH assay buffer), the plate was shaken and incubated for 
30 minutes at RT. One µl of LDH was used as a positive control to test whether all reagents 
were working properly. Finally the absorbance was read at 450 nm and the cytotoxicity was 
calculated using the following formula: 
 
Cytotoxicity (%) = ((Asample - Alow control) / (Ahigh control - Alow control)) x 100   
 
For the calculation, absorbance values were used (blank subtracted). 
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3.5 Oxidative damage by Enzyme-Linked ImmunoSorbent Assay 
(ELISA) 
3.5.1 Principle of ELISA 
 ELISA is a method used for measuring the concentration of a specific analyte with 
the use of a highly specific antibody. As there are three different assay formats used in this 
work, the principles of each of them are mentioned in respective chapters. 
3.5.2 Determination of oxidative DNA damage  
3.5.2.1 DNA extraction and sample preparation 
 Tubes with frozen cell pellets were removed from –80 °C and thawed at room 
temperature. 1 ml of extraction buffer and 20 μl of RNAse mix were added, tubes were 
vortexed and incubated 1 hour at 37 °C. Following the incubation, 20 μl of proteinase K 
was added and samples were incubated for another 1.5 h at 37 °C. The supernatants were 
transferred to 15 ml tubes containing Phase Lock Gel, 1 ml of CI with antioxidant was 
added, the samples were shaken vigorously and centrifuged 5 min, 1800 g. DNA 
precipitation followed by removing the upper phase and mixing it well with 100 μl of 5M 
sodium chloride and 2.2 ml of ice-cold absolute ethanol. Precipitated DNA was then 
removed with a pipette tip, transferred into a new 1.5 ml tube, washed with 70% ethanol 
and spun 5 minutes, 7,250 g. DNA pellet was vacuum-dried and stored at –80 °C. 
 To dissolve DNA, PBS with 1mM DFA was added and DNA pellet was 
homogenized using the Pellet Pestle Motor. Subsequently the samples were incubated 
40 minutes at 55 °C. Dissolved DNA samples were then denatured 5 minutes at 100 °C and 
fragmented using a syringe and a 22G needle. Finally the absorbance at 260 nm was read to 
determine the DNA concentration, which was then adjusted by PBS with 1mM DFA to 
0.75 - 1.25 mg/ml. 
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3.5.2.2 8-oxodG levels in DNA by ELISA 
 
Principle of the assay 
The 8-oxodG ELISA is a competitive assay based on the published protocol (YIN 
et al. 1995), with some modifications. The modifications include changes in incubation 
steps, the use of a different primary antibody (RÖSSNER et al. 2007) and changes in DNA 
extraction as well as DNA samples processing before the ELISA assay. 
ELISA plates used in the assay are first coated with the 8-oxoG-BSA conjugate. 
Then, analysed samples along with the primary antibody are added. 8-oxodG in the samples 
competes with the 8-oxoG-BSA conjugate adsorbed to the plate for binding to the antibody. 
The unbound material is washed and the secondary antibody conjugated with alkaline 
phosphatase is pipetted to the wells. 8-oxodG in samples is detected by adding the substrate 
to alkaline phosphatase and reading the absorbance at 405 nm. The absorbance is inversely 
proportional to the amount of 8-oxodG in analysed samples. 
 
8-oxoG-BSA conjugate preparation 
8-oxoG-BSA conjugate was previously prepared by Pavel Rössner, Jr. according to 
the protocol described by YIN et al. (1995). 8-oxoG was treated with sodium periodate to 
form the electrophilic dialdehyde species that are subsequently conjugated to the amino 
groups of the carrier protein (BSA). Reduction of the Schiff’s base with sodium 
cyanoborohydride forms a stable conjugate. 
Three mg of 8-oxoG (Cayman Chemical Company, USA) were dissolved in 100 µl 
of 0.1 M sodium periodate and incubated on ice for 15 min. BSA (5 mg) was dissolved in 
400 µl of 0.15 M NaCl and slowly mixed with 8-oxoG. pH of the solution was adjusted to 
8.5-9.0 using 0.15 M Na2CO3 (pH 12.0); the solution was stirred on ice for 20 min. Finally, 
150 µl of 0.25% sodium cyanoborohydride was added, pH was adjusted to 7.0 with 
1M acetic acid and the solution was stirred on ice for 40 min. The solution was dialysed 
against PBS in the cold room overnight and the modification level of BSA (n) was 
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estimated by measuring absorbances at 260 nm and 280 nm and using the following 
formula: 
n = [ c(280) * (A260/A280) - c(260)]/ [ N(260) - N(280) * (A260/A280)] 
 
c – molar extinction coefficient of the carrier protein;  
 BSA: c(280) = 4.3x10
4
, c(260) = 2.6x10
4 
N – molar extinction coefficient of the nucleotide;  
 8-oxoG: N(280) = 1.16x10
4
, N(260) = 8x10
3
 
 
The conjugate was stored in small aliquots (5 µl) at -20 °C. It can be repeatedly 
thawed and frozen without changing its properties. 
8-oxodG ELISA assay 
 For coating the plate (Corning 3690, Half Area Plates, Corning, USA), 8-oxoG-
BSA conjugate was used (5 ng in 25 μl PBS per well) and the plate was incubated at 37 °C 
overnight. 
 The next day, the plate was washed with washing buffer and blocked with 100 μl of 
blocking buffer per well for 1 h at RT. The standard curve was prepared by diluting the 
8-oxodG standard (concentration of stock solution: 1 mg/ml) in PBS to the following 
concentrations: 40, 20, 10, 5, 2.5 and 1.25 ng/ml. After the incubation, the blocking 
solution was removed and the samples and standards were added to the plate (25 μl per 
well). To determine total binding, three wells were left without competitor, which was 
replaced by PBS only (25 μl per well). The primary antibody N45.1 was diluted 1:500 in 
blocking buffer to the final concentration 0.2 μg/ml and added (25 µl per well) to all wells 
except blank wells, which were supplied with 25 µl of PBS and 25 μl of blocking buffer. 
The plate was incubated 90 minutes at RT then it was washed and 50 μl of the secondary 
antibody (anti-mouse, alkaline phosphatase conjugated, diluted 1:750) was added to all 
wells. After 90 minutes of incubation with 50 μl of the secondary antibody at RT, the plate 
was washed, rinsed once with 0.01M diethanolamine solution and 50 μl of substrate per 
well was added (p-nitrophenyl phosphate, 1 mg/ml, 1 tablet in 5 ml of 1M diethanolamine, 
Sigma-Aldrich). Plate was incubated 20-60 minutes at RT and then absorbance was read at 
405 nm. Results were calculated using the standard curve. 
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3.5.3 Determination of oxidative damage to proteins and lipids 
3.5.3.1 Preparation of cell lysates for protein carbonyl and 15-F2t-isoprostane 
analysis 
The samples (cell pellets) were mixed with 100 μl of CelLytic reagent, incubated 
for 15 minutes at RT on a shaker and vortexed every 5 minutes. Then the samples were 
centrifuged 15 minutes at 17,750 g at 4 ºC. The supernatant (cell lysate) was transferred to 
a new tube and stored at -80 ºC.  
The lysate (5 μl) was diluted 5x in dH2O and used for the determination of total 
protein concentration. 
3.5.3.2 Determination of total protein concentration 
Using 30 mg BSA and dissolving it in 1 ml of dH2O, the stock solution of BSA was 
made. Then the standard curve was prepared by diluting the BSA stock solution in dH2O to 
the following concentrations: 3.0, 2.5, 2.0, 1.5, 1.0 and 0.5 mg/ml. Diluted BSA standards 
and cell lysates (10 μl) were added to a 96-well plate in duplicates. Bicinchoninic acid 
(20 ml) was mixed with 400 μl of copper sulphate solution and 200 μl/well of the solution 
was added to the samples in the 96-well plate. The plate was incubated 30 minutes at 37 ºC 
and then the absorbance at 562 nm was read. Total protein concentration was calculated 
using the standard curve and the dilution factor 5. 
3.5.3.3 15-F2t-isoprostane concentration in cell lysates by ELISA 
Principle of the assay 
The 15-F2t-isoprostane ELISA is a competitive assay. It is based on a competition 
between 15-F2t-IsoP in analysed samples and a 15-F2t-IsoP-acetylcholinesterase (AChe) 
conjugate (15-F2t-IsoP AChe Tracer) for a limited number of 15-F2t-IsoP-specific rabbit 
antiserum binding sites. Because the concentration of the 15-F2t-IsoP tracer is constant 
while the concentration of 15-F2t-IsoP in the samples varies, the amount of 15-F2t-IsoP 
tracer that is able to bind to the rabbit antiserum is inversely proportional to the 
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concentration of 15-F2t-IsoP in the sample. The rabbit antiserum-15-F2t-IsoP complex binds 
to the anti-rabbit IgG mouse monoclonal antibody that was previously attached to wells of 
the 96-well ELISA plate. The unbound reagents are removed from the plate by washing and 
the Ellman’s Reagent, which contains the substrate to AChe, is added. The absorbance of 
the product of the enzymatic reaction is inversely proportional to the amount of 15-F2t-IsoP 
in analysed samples. 
Before running the ELISA assay, the membrane-bound 15-F2t-IsoP must be 
hydrolysed and the samples purified. 
Sample purification 
Cell lysates samples containing 50 μg of proteins were transferred into 1.5 ml tubes 
and diluted with dH2O to 100 μl. Then 100 μl of 15% KOH was added, the samples were 
vortexed and incubated 60 minutes at 40 °C. The pH of the samples was adjusted by adding 
300 μl of 1 M KH2PO4 (resulting pH around 7.3). Consecutively, 100 μl of column buffer 
was added and the samples were mixed. As a next step, 50 μl of Isoprostane Affinity 
Sorbent was added and the samples were incubated 60 minutes at RT on a shaker. After 
the incubation, the samples were centrifuged 1 minute at 5,000 g and the supernatant was 
decanted. The washing step followed by adding 1 ml of dH2O, vortexing, centrifuging 
1 minute at 5,000 g and finally by decanting the supernatant. The procedure of purification 
of the 15-F2t-IsoP continued by its elution from the sorbent: the pellets were resuspended in 
0.5 ml of Elution solution (95% ethanol), vortexed and centrifuged 1 minute at 5,000 g. 
The supernatant (ethanol wash) was removed and stored in a 1.5 ml tube and the elution 
step was repeated. Both supernatants were combined and stored at –80 °C until analysis. 
15-F2t-isoprostane ELISA assay 
 The samples were vacuum-dried, resuspended in 110 μl of EIA buffer and 
immediately used for the assay. The ELISA itself was performed according to 
the manufacturer’s recommendations: 
 The 8-Isoprostane standard (50 ng/ml) was diluted ten times to prepare “the bulk 
standard” (5 ng/ml). This bulk standard was then diluted to eight different concentrations to 
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prepare the standard curve: 500, 200, 80, 32, 12.8, 5.1, 2.0 and 0.8 pg/ml. Each 
concentration of the standard was then added to the plate in duplicate (50 μl per well). 
The prepared samples were analysed in duplicates as well (50 μl per well). The 96-well 
plate also contained two blanks (Blk), two non-specific binding wells (NSB), three 
maximum binding wells (B0) and one total activity well (TA, total enzymatic activity of 
the AChE-linked tracer). To NSB wells 100 μl of EIA buffer was added, for B0 wells 
the volume of buffer was 50 μl. Consecutively, 50 μl of AChE Tracer was added to each 
well except the TA and Blk wells. Finally, 50 μl of 15-F2t-IsoP Antiserum was added to 
each well except the TA, the NSB, and the Blk wells and the plate was covered with the 
plastic film and incubated for 18 hours at 4 °C. When ready to develop the plate, the wells 
were rinsed five times with the Wash Buffer (250 μl per well) and the substrate was added 
(200 μl per well, the Ellman’s Reagent – one vial dissolved in 20 ml of dH2O). Lastly, 5 μl 
of Tracer was added to the TA well, the plate was covered with the plastic film and 
developed in the dark for 60-90 minutes. Later on, the plate was read at 405 nm and 
the results were calculated using the standard curve. 
 
3.5.3.4 Protein carbonyl concentration in cell lysates by ELISA 
Principle of the assay 
The carbonyl assay is an indirect ELISA method described by BUSS et al. 1997. 
The original method was developed for the analysis of protein carbonyls in blood plasma; 
however, it was modified in our laboratory to make it suitable for the analysis of cell 
lysates. Before running the assay, oxidised BSA was prepared and the concentration of 
carbonyl groups was measured using a colorimetric method. Oxidised BSA with known 
levels of proteins oxidation was used to make a standard curve during the ELISA assay. 
Oxidised BSA may be kept at -80 °C for a long time (several years) without any change of 
level of oxidation. 
The principle of the detection of carbonyl groups in analysed samples is based on 
the incubation of the samples with dinitrophenylhydrazine (DNPH). During the process 
called derivatisation, DNPH binds to carbonyl groups and changes to 
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dinitrophenylhydrazon. A 96-well ELISA plate is coated with derivatised samples and 
modified carbonyl groups are detected using a biotinylated primary antibody recognising 
dinitrophenyl and a streptavidin-horseradish peroxidase conjugate. Finally the enzymatic 
reaction is started by adding the peroxidase substrate. The more carbonyl groups are 
present in the sample, the stronger enzymatic reaction occurs. 
Preparation of the oxidised standards 
 Oxidation of BSA 
 Oxidised BSA stock standard was previously prepared by Pavel Rössner, Jr. by 
the following procedure: 
 FeSO4.H2O was dissolved in PBS to a final concentration 0.42 mM Fe
2+
, H2O2 was 
added to a final concentration 0.73 M H2O2. BSA (50 mg/ml) was dissolved in the solution 
and incubated for 1h at 37 °C in a water bath. Oxidation was stopped with butylated 
hydroxytoluene (a final concentration 40 μM). 
 
 Carbonyl and protein concentration in oxidised and unoxidised (native) BSA 
 Native (unoxidised) BSA was dissolved in PBS (final concentration 50 mg/ml). 
Both oxidised and native BSA (0.25 ml) were added to 3.6 ml tubes, two tubes for each 
sample. DNPH (1 ml; stock solution 10 mM in 2.5M HCl) was added to one of the tubes 
with oxidised or native BSA; the solution served as a sample. 2.5M HCl (1 ml) was added 
to the other tube with oxidised or native BSA; it served as a control without DNPH. 
Solutions were incubated for 1 h at RT in the dark, vortexed every 15 min. Then 1 ml of 
20% trichloroacetic acid was added and samples were incubated on ice for 10 min. 
The tubes were centrifuged at 1800 g for 5 min, the supernatant was discarded and 
the sediment washed three times with 1 ml of the ethanol-ethyl acetate mixture (1:1, v/v). 
Finally, the supernatant was dissolved in 0.5 ml of 6M guanidine hydrochloride and 
incubated at 37 °C for 10 min. Tubes were centrifuged again (1800 g, 5 min) to remove any 
insoluble material. The concentration of proteins in samples was measured by reading 
the absorbance of the samples at 280 nm and comparing with the standard curve 
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constructed by diluting native BSA (stock solution 50 mg/ml) in guanidine hydrochloride 
to final concentrations 2.0, 1.5, 1.0, 0.5 and 0.25 mg/ml. To estimate the level of carbonyl 
groups (nmol/ml), the absorbance of the samples at 375 nm was measured and the result 
was multiplied by a constant 45.45. Then the value obtained for controls without DNPH 
was subtracted from the value obtained for samples (containing oxidised or native BSA). 
The carbonyl concentration normalized per mg of protein (nmol/mg protein) was further 
calculated by dividing the carbonyl levels expressed in nmol/ml by the concentration of 
proteins in control samples. To make a standard for the carbonyl ELISA, native and 
oxidised BSA were mixed in various ratios and the dilution that gives the final carbonyl 
concentration 1.9-2.0 nmol/mg protein was determined. In this solution, the protein 
concentration is 50 mg/ml. To reduce the protein concentration to 4 mg/ml, the mixture of 
oxidised and native BSA was diluted 12.5x with PBS. The final solution containing 
1.9-2.0 carbonyl groups/mg protein, the protein concentration 4 mg/ml, was stored in 
aliquots at -80 °C and used as a standard for the carbonyl ELISA assay. 
 
Preparation of samples and standards - derivatisation 
 The standard curve was made by diluting the stock standard BSA with PBS to 
the following concentrations of carbonyl: 0.612, 0.510, 0.408, 0.306, 0.204 and 
0.102 nmol/mg protein. The analysed samples were diluted with PBS to a final protein 
concentration of 2 mg/ml. 10 μl of the samples and standards were mixed with 10 μl of 
derivatisation solution to give a final protein concentration of 1 mg/ml. The samples were 
incubated at room temperature in the dark for 45 min and vortexed every 10 to 15 min. 
The derivatisation process was stopped by adding 30 μl of 2M Tris; then the samples were 
mixed on a shaker and briefly centrifuged. 6.25 μl of the derivatised samples were added to 
1.25 ml of the coating buffer, mixed and used for coating the ELISA plates. 
Carbonyl ELISA assay 
Samples and standards were added to the plate in triplicates (200 μl per well) to coat 
the plate overnight at 4 ºC in humidified atmosphere. Derivatised PBS was used as a blank. 
The next day, the plate was washed with 350 μl of wash buffer per well and blocked with 
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0.1% BSA in PBS (250 μl per well) at RT for 1.5 hour. After blocking, the plate was 
washed again and 200 μl of primary antibody was added (biotinylated anti-DNP antibody 
diluted 1:1500 in 0.1% BSA, 0.1% Tween 20 in blocking buffer containing 0.1% Tween 
20). After the incubation with the antibody (1 h at 37 ºC), the plate was washed again and 
200 μl of conjugate (streptavidin-biotinylated horseradish peroxidase conjugate diluted 
1:4000 in blocking buffer containing 0.1% Tween 20) was added and incubated at RT for 
1 hour. After the incubation with the conjugate the plate was washed, and incubated with 
TMB substrate (200 μl per well) at RT for 15 – 25 minutes. Finally, the reaction was 
stopped by adding 2.5M sulphuric acid (H2SO4, 100 μl per well) and the absorbance was 
read at 450 nm. Subtracting the blank absorbance value and using the standard curve, 
the carbonyl concentration in samples was calculated.  
 
3.6 Equipment used  
Incubator IG 150 – (Jouan, France) 
Microscope CKX41 – (Olympus, Japan)  
Biohazard hood LC2S.18 – (Jouan, France) 
Pellet Pestle Motor - (Sigma Aldrich, USA)   
Nanodrop spectrophotometer ND-1000 – (Thermo Scientific, USA) 
Centrifuge 5810 R – (Eppendorf, Germany) 
Centrifuge MR 22i - (Jouan, France) 
Centrifuge Speedfuge 24D – (Labnet International, USA) 
Water bath 1086 – (GFL, Germany) 
pH meter 50 – (Beckman Coulter, USA)  
Minishaker MS1 – (IKA, Germany)  
Analytical balance RC 210D – (Sartorius, Germany) 
Microplate strip washer ELx 50 – (BIO-TEK, USA) 
Spectrophotometer SpectraMax M5e – (Molecular Devices, USA) 
Pipettes Eppendorf Research – adjustable single channel and 8-channel – (Eppendorf, 
Germany) 
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3.7 Statistical analysis 
 To ensure maximum reliability of the data and to control for inter-experiment 
variability, each tested compound was analysed in a triplicate and the whole experiment 
was repeated at least twice. The data from two or more experiments were pooled and 
analysed together. As described further in the Results chapter, the biological inter-
experiment variability was quite high. For that reason, the results of every experiment were 
normalised to the basal level of oxidative damage in the control sample, and these relative 
numbers were pooled and used for the statistical analysis.   
 The data obtained from the experiments were calculated and processed using 
Microsoft Excel 2007. The graphs, also created in Microsoft Excel, show mean values of 
relative oxidative damage levels ± standard deviation.  
 Statistical differences between the levels of oxidative damage determined in treated 
cells and controls were calculated by Student’s t-test using SPSS programme (version 
16.0). The null hypothesis (H0) tested was that the data obtained from the treated samples 
do not significantly differ from the data obtained from the control samples. The null 
hypothesis was rejected on the 5% significance level (p<0.05). 
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4 RESULTS 
4.1 Cytotoxicity of the tested chemicals 
 The cytotoxicity of individual c-PAHs (B[a]P, DB[a,l]P), the artificial mixture of 
c-PAHs and EOM measured by the LDH kit differed between the two cell lines. Generally, 
the amount of LDH released from HepG2 cells was higher than that released from HEL 
cells, suggesting that the hepatoma cell line was more sensitive to the tested compounds.  
 For EOM, the cytotoxic effect on both cell lines was quite similar: EOM from 
summer 2000 was cytotoxic at a concentration of 50 µg/ml for both treatment periods in 
HepG2 cells, while in HEL cells this concentration was cytotoxic only after 48 h 
incubation. No cytotoxicity of EOM from either winter period (2001 or 2005) was observed 
for either cell line.  
 However, the cytotoxic responses of the cell lines to exposure to B[a]P and 
DB[a,l]P was different. While exposure to the higher concentrations of B[a]P and DB[a,l]P 
resulted in increased LDH release from HepG2 cells already after 24 h incubation, the only 
compound increasing the cytotoxicity in HEL cells was DB[a,l]P at the higher tested 
concentration and after 48 h treatment. 
 Even though the levels of cytotoxicity in treated cells were higher when compared 
to the control samples, the amount of released LDH was generally low and the percentage 
of cytotoxicity rarely exceeded 20%. The concentrations of the tested chemicals resulting in 
cytotoxicity > 20% are indicated by the letter “C” in Graphs 1-12.    
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4.2 Oxidative damage to macromolecules 
 The results of oxidative damage to macromolecules are shown separately for 
oxidative damage to DNA, lipids and proteins. Each chapter presents the results for all 
tested compounds and mixtures, both cell lines and both treatment periods. As described in 
the Materials and methods chapter, oxidative damage is expressed as a relative number, 
rather than as the absolute value of the respective marker of oxidative stress (Graphs 1-12). 
The reason why the data were analysed in this way is the variability of the basal levels of 
oxidative damage between individual experiments and also the fact that measurements from 
at least two independent experiments were pooled and statistically analysed together. 
 The mean values of the oxidative stress markers, the standard deviations and 
the coefficient of variation (CV, calculated as the ratio of the standard deviation and the 
mean, expressed in %) illustrating the variability between the experiments are shown in 
Table 4. These values were obtained from control cells incubated in culture media with 
DMSO only. The CV, ranging between 27.3% and 68.2 %, cannot be explained by the 
inter-assay variability of the ELISA assay, which typically has a maximum CV of 15%. 
This variability is rather a result of the biological variability in the basal levels of oxidative 
damage between individual experiments. Despite the observed variability, significant 
differences between the two cell lines were found for all markers of oxidative stress: HEL 
cells had higher levels of basal oxidative damage than did HepG2 cells. 
 
Table 4. Variability in the basal levels of oxidative markers and a comparison of the HepG2 and HEL cell 
 lines.  
Oxidative stress 
marker 
8-oxodG  
(per 10
5
 dG) 
15-F2t-IsoP  
(pg/ml) 
Carbonyl  
(nmol/mg) 
Cell line HepG2 HEL HepG2 HEL HepG2 HEL 
Mean 1.50 4.28 23.84 41.96 0.92 1.14 
SD 1.03 2.54 8.23 13.24 0.36 0.31 
CV (%) 68.17 59.32 34.51 31.54 39.07 27.26 
Comparison  
HepG2 vs. HEL 
p<0.001 p<0.001 p=0.001 
SD – standard deviation; CV – coefficient of variation 
Mean and SD were calculated from at least 35 individual values of the respective marker of oxidative stress. 
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4.2.1 Oxidative DNA damage 
 Graphs 1 and 2 summarise the results of analyses of 8-oxodG obtained for HepG2 
and HEL cells following the treatment with B[a]P, DB[a,l]P and the c-PAH mix for 24 and 
48 h. The effect of the tested compounds was weak. In HepG2 cells some increase in 
8-oxodG levels was detected after 48 h of treatment with B[a]P, DB[a,l]P and the c-PAH 
mix, but in HEL cells no significant increase in 8-oxodG compared to the control occurred.  
 Oxidative DNA damage induced by EOM is shown in Graph 3 (HepG2) and 
Graph 4 (HEL). In HepG2 cells, the levels of 8-oxodG significantly increased 
above control levels for all EOM and most concentrations and treatment periods tested. 
However, in HEL cells no significant increase above control levels was observed. With 
the exception of the summer 2000 EOM after the 24 h treatment in HepG2 cells, no 
apparent dose-response was detected. Differences between the 24 h and 48 h treatment 
periods in HepG2 cells were not consistent: a significant decrease in the levels of 8-oxodG 
was observed for all concentrations of the winter 2001 EOM (p<0.05) and for the lower 
concentration of the winter 2005 EOM (p<0.01). For the summer 2000 EOM, no significant 
differences between 24 h and 48 h incubations were found.  
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Graph 1. 8-oxodG levels in HepG2 cells after the treatment with B[a]P, DB[a,l]P or the c-PAH mix for 24 or 
 48 h 
 
Graph 2. 8-oxodG levels in HEL cells after treatment with B[a]P, DB[a,l]P or the c-PAH mix for 24 or 48 h 
 
Mean relative levels of DNA oxidation ± standard deviation; the solid line indicates the basal level of DNA 
oxidation in the controls.  
c-PAH mix: values on the x-axis indicate the concentrations of B[a]P in the mixture; the concentrations of 
the other c-PAHs were calculated in relation to B[a]P content as described in the Materials and methods 
chapter. 
The significant differences between oxidative DNA damage in the experimental samples compared to 
the control are indicated by asterisks; significance level: p < 0.05 (*), p  0.01 (**), p  0.001 (***).  
“C” denotes a dose of a compound that increases the release of lactate dehydrogenase by more than 20% 
compared to the control sample. 
B[a]P – benzo[a]pyrene; DB[a,l]P – dibenzo[a,l]pyrene; c-PAH mix – an artificial mixture of c-PAHs 
c-PAHs – carcinogenic polycyclic aromatic hydrocarbons. 
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Graph 3.   8-oxodG levels in HepG2 cells after treatment with EOM for 24 or 48 h 
 
 
Graph 4.   8-oxodG levels in HEL cells after treatment with EOM for 24 or 48 h 
 
Mean relative levels of DNA oxidation ± standard deviation; the solid line indicates the basal level of DNA 
oxidation in the controls. 
The significant differences between oxidative DNA damage in the experimental samples compared to 
the control are indicated by asterisks; significance level: p < 0.05 (*), p  0.01 (**), p  0.001 (***).  
“C” denotes a dose of a compound that increases the release of lactate dehydrogenase by more than 20% 
compared to the control sample. 
EOM – organic extract from respirable air particles. 
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4.2.2 Lipid peroxidation 
 Individual c-PAHs as well as the c-PAH mix either had no significant effect on 
the levels of lipid peroxidation in HepG2 cells, or else they decreased 15-F2t-IsoP 
concentrations below control levels after 24 h incubation, but increased them above control 
levels after 48 h treatment (Graph 5). The effect of c-PAHs and the c-PAH mix on lipid 
peroxidation in HEL cells differed from that observed in HepG2 cells. The levels of 
15-F2t-IsoP remained at control levels or even decreased for most concentrations in both 
treatment times (Graph 6).  
 This unexpected trend in HEL cells was even more pronounced after the treatment 
with EOM: the decrease was significant for all concentrations and both incubation periods 
with the only exception of the winter 2001 EOM, concentration 10 µg/ml and 48 h, where 
the decrease was not significant due to high variability of the data (Graph 8). 
On the contrary, in HepG2 cells exposure to EOM lead to similar results for lipid 
peroxidation as for DNA oxidation. As Graph 7 indicates, 15-F2t-IsoP levels were 
significantly increased compared to the control for most concentrations of EOM. The 48 h 
treatment did not result in increase of 15-F2t-IsoP above the levels observed after 24 h. 
In several cases, however, the levels significantly decreased (EOM winter 2001, 25 µg/ml, 
p<0.05; EOM winter 2005, 10 µg/ml, p<0.05 and 25 µg/ml, p<0.01). 
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Graph 5. 15-F2t-IsoP levels in HepG2 cells after treatment with B[a]P, DB[a,l]P or the c-PAH mix for 24 or 
 48 h 
Graph 6. 15-F2t-IsoP levels in HEL cells after treatment with B[a]P, DB[a,l]P or the c-PAH mix for 24 or 
 48 h  
 
Mean relative levels of lipid peroxidation ± standard deviation; the solid line indicates the basal level of lipid 
peroxidation in the controls.  
c-PAH mix: values on the x-axis indicate the concentrations of B[a]P in the mixture; the concentrations of 
other c-PAHs were calculated in relation to B[a]P content as described in the Materials and methods chapter. 
The significant differences between lipid peroxidation in the experimental samples compared to the control 
are indicated by asterisks; significance level: p < 0.05 (*), p  0.01 (**), p  0.001 (***). 
“C” denotes a dose of a compound that increases the release of lactate dehyrogenase by more than 20% 
compared to the control sample. 
B[a]P – benzo[a]pyrene; DB[a,l]P – dibenzo[a,l]pyrene; c-PAH mix – an artificial mixture of c-PAHs 
c-PAHs – carcinogenic polycyclic aromatic hydrocarbons. 
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Graph 7. 15-F2t-IsoP levels in HepG2 cells after treatment with EOM for 24 or 48 h 
 
 
 
Graph 8. 15-F2t-IsoP levels in HEL cells after treatment with EOM for 24 or 48 h 
 
Mean relative levels of lipid peroxidation ± standard deviation; the solid line indicates the basal level of lipid 
peroxidation in the control.  
The significant differences between lipid peroxidation in the experimental samples compared to the control 
are indicated by asterisks; significance level: p < 0.05 (*), p  0.01 (**), p  0.001 (***).  
“C” denotes a dose of a compound that increases the release of lactate dehydrogenase by more than 20% 
compared to the control sample.  
EOM – organic extract from respirable air particles. 
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4.2.3 Protein oxidation 
 The effect of individual c-PAHs on protein oxidation in HepG2 cells was not 
consistent. Generally, there was no effect after 24 h incubation. Slightly decreased levels of 
protein oxidation were observed for B[a]P and DB[a,l]P at cytotoxic concentrations 
(Graph 9) after 24 h treatment. Increased protein carbonyl levels were found for the highest 
concentration of B[a]P after 48 h of incubation (Graph 9). An increase in protein oxidation 
was also observed for both concentrations of the c-PAH mix after 48 h of incubation. 
The results obtained for HEL cells slightly differed from those seen in HepG2 cells. 
The 24 h incubation period had generally no effect on protein oxidation. A decrease of 
the carbonyl levels was observed only with the lowest concentration of B[a]P (Graph 10). 
Protein oxidation in HEL cells was induced after 48 h treatment with B[a]P and DB[a,l]P 
and also by the higher tested dose of c-PAH mix (Graph 10). 
  None of the tested EOM significantly increased carbonyl levels above the controls 
in either cell line after 24 h of incubation (Graphs 11 and 12). In HepG2 cells, oxidative 
damage to proteins mostly occurred after 48 h treatment with the higher tested 
concentrations of EOM. The difference between the two incubation periods, however, was 
not significant except for the highest tested concentrations of EOM from summer 2000 
(p<0.01) and winter 2001 (p<0.05). For HEL cells, the only significant increase in carbonyl 
levels following the treatment with EOM was detected for the winter 2005 EOM, the higher 
tested concentration (25 µg/ml).   
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Graph 9. Protein carbonyl levels in HepG2 cells after treatment with B[a]P, DB[a,l]P or the c-PAH mix for 
 24 or 48 h 
 
 
Graph 10. Protein carbonyl levels in HEL cells after treatment with B[a]P, DB[a,l]P or the c-PAH mix for 24 
     or 48 h  
Mean relative levels of protein oxidation ± standard deviation; the solid line indicates the basal level of 
protein oxidation in the control.  
c-PAH mix: values on the x-axis indicate concentrations of B[a]P in the mixture; the concentrations of 
the other c-PAHs were calculated in relation to B[a]P content as described in the Materials and methods 
chapter. 
The significant differences between protein oxidation in the experimental samples compared to the control are 
indicated by asterisks; significance level: p < 0.05 (*), p  0.01 (**), p  0.001 (***).  
“C” denotes a dose of a compound that increases the release of lactate dehydrogenase by more than 20% 
compared to the control sample. 
B[a]P – benzo[a]pyrene; DB[a,l]P – dibenzo[a,l]pyrene; c-PAH mix – an artificial mixture of c-PAHs 
c-PAHs – carcinogenic polycyclic aromatic hydrocarbons. 
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Graph 11. Protein carbonyl levels in HepG2 cells after treatment with EOM for 24 or 48 h  
 
 
Graph 12. Protein carbonyl levels in HEL cells after treatment with EOM for 24 or 48 h 
 
Mean relative levels of protein oxidation ± standard deviation; the solid line indicates the basal level of 
protein oxidation in the control.  
The significant differences between protein oxidation in the experimental samples compared to the control are 
indicated by asterisks; significance level: p < 0.05 (*), p  0.01 (**), p  0.001 (***).  
“C” denotes a dose of a compound that increases the release of lactate dehydrogenase by more than 20% 
compared to the control sample. 
EOM – organic extract from respirable air particles. 
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5 DISCUSSION 
 B[a]P as well as DB[a,l]P are known carcinogens (IARC, in preparation). However, 
the exact mechanism of their carcinogenic potency is still under investigation. The major 
pathway responsible for carcinogenicity of these two compounds was thought to be via 
their bioactivation to the diol-epoxide metabolic intermediates and DNA adducts formation 
(THAKKER et al. 1976, YANG et al. 1976, RALSTON et al. 1994, 1995, NESNOW et al. 
1997, 1998a, XUE and WARSHAWSKY 2005). However, there is growing evidence that 
during metabolic activation, c-PAHs can also produce various quinone derivatives and 
subsequently cause the ROS formation (PENNING et al. 1996, BURCZYNSKI et al. 
1998). The formation of ROS and consecutive oxidative damage to DNA is also thought to 
play an important role in the process of c-PAH-mediated carcinogenesis (TRUSH and 
KENSLER 1991, WITZ 1991, GUYTON and KENSLER 1993, KLAUNIG and 
KAMENDULIS 2004). 
 Exposure to higher levels of PM10 or PM2.5 is associated with higher risk of lung 
cancer and mortality from cardiopulmonary diseases (ABBEY et al. 1999, POPE et al. 
2002, BOLDO et al. 2006). One hypothesis is that the free radical generating activity of 
respirable air particles underlies much of their adverse health effects (DONALDSON et al. 
2003, SHI et al. 2003). However, the identification of components which are responsible 
for oxidative stress induction by PM is the matter of ongoing investigation.   
 The principal aim of the present master thesis was to determine whether c-PAHs 
(B[a]P, DB[a,l]P) alone are able to induce oxidative damage to macromolecules and how 
this potential ability is affected by the interactions between c-PAHs in the artificial mixture, 
or by other compounds in EOM prepared by organic extraction from PM. To achieve this 
goal two individual c-PAHs were selected:  B[a]P, probably the best characterised and most 
often studied c-PAH, and DB[a,l]P, the most potent c-PAH ever tested (NESNOW et al. 
1997, 1998a, BINKOVÁ and ŠRÁM 2004). An artificial c-PAH mixture and three different 
EOM were also employed. The content of c-PAHs (excluding DB[a,l]P, which is normally 
present in the air in non-detectable concentrations) in all tested EOM was analysed in the 
study of SEVASTYANOVA et al. (2008) and is summarised in Materials and methods 
chapter in Table 1. 
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 The cell lines selected for the experiments are able to activate c-PAHs and form 
bulky DNA adducts, though the ability to induce DNA adducts was 10 to 100-fold higher 
in HepG2 than in HEL cells in the study of SEVASTYANOVA et al. (2007). Moreover, 
BURCZYNSKI and PENNING (2000) showed that the activity of CYP enzymes in HepG2 
cells was feedback stimulated by o-quinones (formed by the action of CYPs and epoxid 
hydrolase) that act as bifunctional inducers affecting both phase II detoxification and phase 
I activation enzymes. 
 This work is probably the first in which the biomarkers of oxidative damage to 
DNA, lipids and proteins were used along with the combination of different c-PAHs and 
EOM, two cell lines and two treatment periods. As oxidative stress is a complex process, 
the simultaneous use of the three biomarkers as well as the employment of different cell 
lines and treatment periods was proposed to have a better chance of revealing potential 
differences in the mechanisms of oxidative stress induction by individual c-PAHs, their 
mixture and EOM.  
5.1 c-PAHs 
 Several in vitro studies concerning the induction of oxidative damage by B[a]P have 
been published and their results are summarised below: 
 GÁBELOVÁ et al. (2007) did not find any significant increase of oxidative base 
lesions (measured by a modified SCGE with Fpg) following exposure of HepG2 cells to 
B[a]P in the concentration range 1-7.5 µM for different treatment periods (2, 24 or 48 h). In 
the study conducted by PARK et al. (2006), B[a]P at concentrations 0.1, 1, 4 and 10 µM 
induced nonspecific DNA damage (measured by the SCGE) after 24 h treatment of HepG2 
cells. B[a]P-treated cells showed increased MDA formation, but the statistically significant 
difference was found for 1 µM concentration only. On the other hand all tested 
concentrations resulted in the increased catalase activity in treated cells, but without any 
concentration-dependent response. In the A549 cell line, GARCON et al. (2001b) tested the 
effect of B[a]P treatment on lipid peroxidation (MDA), antioxidant enzyme activities 
(SOD, GPx and GR), glutathione status (GSSG/GSH) and alpha-tocopherol consumption. 
They exposed the cells to 0.05 µM B[a]P for 72 h but found no increase of MDA levels. 
However, exposure to B[a]P was accompanied by decreases in the levels of reduced 
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glutathione (GSH) and alpha-tocopherol. Thus, the authors concluded that the non-
enzymatic defences might be active enough to prevent a free radical-induced injury in cells 
exposed to B[a]P. Finally, MAUTHE et al. (1995) treated Syrian hamster embryo and 
human mammary carcinoma (MCF-7) cell lines for 24 h with different concentrations of 
B[a]P up to 20 µM and then either exposed them to fluorescent light or kept them in the 
dark. Oxidative damage to DNA measured as levels of 8-oxodG by HPLC with 
electrochemical detection was increased only in cells exposed to fluorescent light. With the 
exception of increased MDA levels in the study of PARK et al. (2006), the results of these 
in vitro studies generally indicate that B[a]P did not increase the levels of oxidative damage 
in treated cells. 
 In accordance with these observations, the results of this thesis show that B[a]P, 
which is effectively metabolised by HepG2, failed to produce any significant levels of 
oxidative damage in HepG2 cells in sub-toxic concentration regardless the time of cell 
exposure. Similar results were obtained for HEL cells, where only significant increase of 
oxidative damage was found for levels of protein carbonyls after the 48 h incubation. 
 For DB[a,l]P, the results of the treatment of HepG2 cells at the sub-toxic 
concentration show significantly increased levels of 8-oxodG and 15-F2t-isoprostanes after 
the 48 h incubation period. Solely the marker of protein oxidation remained at control 
levels. For HEL cells, the oxidative damage to macromolecules at sub-toxic concentrations 
of DB[a,l]P were not observed for any marker tested. To the best of my knowledge, this 
study is the only one analysing the effect of DB[a,l]P on oxidative stress induction. Thus, 
the results cannot be compared with observations of other authors. 
 The treatment of HepG2 cells with c-PAH mix resulted in increased levels of DNA 
and protein oxidation after 48 h of incubation. HEL cells failed to produce oxidative 
damage to DNA and lipids. The only increased marker was again the marker of protein 
oxidation but only for the higher concentration and 48 h incubation.  
 In general, the results for individual c-PAHs and c-PAH mix show differences 
between the two cell lines. The markers of oxidative stress often increased above control 
levels in HepG2 cells, but only after 48 h of incubation, while the overall ability of HEL 
cells to be oxidised by c-PAHs is very limited. These differences may be due to the 
different ability of the cell lines to metabolically activate c-PAHs. As already mentioned, 
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c-PAHs in HepG2 cells induce much higher levels of DNA adducts, which is probably 
caused by the higher activity of PAH-metabolising enzymes. 
 In both cell lines, a significant decrease in oxidative damage below the control level 
was observed for some doses of tested c-PAHs. This effect was particularly observed for 
lipid peroxidation even at sub-toxic concentrations. I have not found any similar results in 
scientific literature nor have I found any explanation for this phenomenon. But it shall be 
mentioned that the number of studies concerning the same issue is rather limited. Since this 
observation arises from independent experiments, I believe it is not a spurious finding 
and/or an experimental error.  
 The ability of the c-PAH mix to induce oxidative damage did not particularly differ 
from the results obtained for B[a]P, suggesting that the presence of other c-PAHs and/or 
their interactions do not substantially affect oxidative stress. 
 
5.2 EOM 
 As already mentioned, many studies have investigated the effect of various types of 
particulate matter on induction of oxidative damage in vitro. The results of these studies 
were affected by the type of particles used and the method of their preparation. Most of 
them used aqueous suspensions of PM. Generally, the results show that the aqueous 
suspensions of PM are able to generate oxidative DNA damage: DANIELSEN et al. (2008) 
compared the effect of respirable authentic street particles (ASP) collected in Copenhagen, 
Denmark and that of standard reference material (SRM) 1650 and SRM 2975 on the 
induction of strand breaks at Fpg-sensitive sites in A549 cells (measured by a SCGE with 
Fpg) and 8-oxodG formation in CT DNA (measured by HPLC with electrochemical 
detection). ASP were obtained from filters by ultrasonication in ultrapure water. The results 
showed that while all types of particles induced DNA damage in A549 cells, in CT DNA 
only ASP were able to generate 8-oxodG. The transition metal content was substantially 
higher in ASP compared to SRM 1650 and 2975 (iron: 37.4 µg/mg, 0.0031 µg/mg and 
0.0009 µg/mg; copper: 2.1 µg/mg, 0.020 µg/mg and not detectable, in ASP, SRM 1650 and 
2975, respectively) while the PAH content was comparable (40 ng/mg, 47 ng/mg and 29 
ng/mg, in ASP, SRM 1650 and 2975, respectively). Thus, the authors concluded that the 
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observed difference is due to higher levels of transition metals in ASP. SHI et al. (2003) 
also investigated the potential of urban air PM (fine and coarse fractions) to induce 
oxidative DNA damage to CT DNA and A549 cells. The PM samples were collected 
during various periods from July to December in Düsseldorf, Germany and subsequently 
resuspended in water. The induction of 8-oxodG was determined using an immunodotblot 
assay (CT DNA) and immunohistochemical staining (A549). The results showed that both 
PM size fractions were able to induce increased levels of 8-oxodG in both systems. 
PRAHALAD et al. (2001) tested the induction of 8-oxodG in free deoxyguanosine, CT 
DNA and human epithelial cells after the treatment with different types of PM. The levels 
of induced 8-oxodG (determined by HPLC with electrochemical detection) depended on 
the type and composition of the particles and the authors concluded that the level of 
oxidative DNA damage in all systems was dependent on the concentration of the water-
soluble content of the PM. GARCON et al. (2006) investigated oxidative stress induction 
following the treatment of human lung epithelial cell line L132 with PM2.5 collected in 
Dunquerque, a French city close to an industrial zone. The cells were incubated with two 
concentrations of PM suspension (18.84 and 75.36 µg PM/ml) for 24, 48 and 72 h and 
oxidative stress was determined. As a marker of lipid peroxidation, MDA production was 
evaluated using HPLC. Formation of 8-oxodG, measured by the 8-oxodG ELISA kit, 
served as a marker of oxidative damage to DNA. The authors observed concentration- and 
time-dependent changes in MDA and 8-oxodG levels. It was also noted that both inorganic 
(metals) as well as organic compounds (including PAHs) were detected in the PM. While 
the above-mentioned studies were mostly concerning the aqueous PM suspensions or 
water-soluble fractions of PM, only a couple of studies investigated the potential of organic 
extracts from PM to induce oxidative damage to macromolecules: GÁBELOVÁ et al. 
(2007) tested eight different EOM to determine their potential to induce oxidative damage 
to DNA (oxidised bases) in HepG2 cells. The levels of oxidative base lesions were 
analysed using a modified SCGE with Fpg. The EOM were extracted by dichloromethane 
from PM10 collected at four monitoring sites: Prague – Smíchov, Prague – Libuš, Košice 
and Sofia in the winter and summer seasons. The HepG2 cells were incubated with 
different concentrations of individual EOM ranging from 5 to 150 µg/ml for 2 h and then 
oxidative damage to DNA was determined. Based on preliminary experiments, the 2 h 
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treatment period was selected, because 24 h and 48 h treatment did not result in increased 
levels of oxidative DNA damage but lead to cytotoxicity. From all EOM tested, only the 
one from Košice summer sampling period induced significant increase in oxidative DNA 
lesions in three (20, 50 and 100 µg/ml) from total six concentrations applied. As authors did 
not find any consistent effect, they concluded that EOM probably plays only a marginal 
role in oxidative stress generation. On the contrary, LAZAROVÁ and SLAMEŇOVÁ 
(2004) found a significant oxidative DNA damage (oxidised bases, measured also by the 
modified SCGE with Fpg) in HepG2 cells following the 24 h treatment with different 
concentrations of EOM extracted from PM10 collected in Teplice during summer and winter 
periods. The pre-treatment of the cells with vitamins C and E significantly reduced the 
oxidative DNA damage caused by EOM exposure. As the c-PAH content in EOM from 
Teplice from winter and summer seasons was comparable with the c-PAH content in EOM 
tested by GÁBELOVÁ, the positive effect found by LAZAROVÁ was not probably caused 
by c-PAHs. 
 The summary of above-mentioned studies may indicate that the composition of PM, 
particularly the presence of water-soluble compounds, is a critical parameter affecting 
the ability of PM to induce oxidative stress. However, the results of this thesis in 
accordance with the results of LAZAROVÁ and SLAMEŇOVÁ (2004) suggest that some 
components present in the organic fraction are also capable of causing oxidative damage to 
DNA, lipids and proteins, specifically in HepG2 cells. 
 It should be mentioned that the concentration of B[a]P (and the other c-PAHs as 
well) in the EOM used for the treatment, was much lower than the concentration of B[a]P 
alone used for the experiments. The concentrations of B[a]P in the 10 µg/ml EOM used for 
treatment were as follows: summer 2000 – 2 nM B[a]P; winter 2001 – 9.3 nM and winter 
2005 – 19.5 nM B[a]P.  
 Similar to the results obtained for individual c-PAHs and the c-PAH mix, the 
induction of oxidative damage to macromolecules in HEL cells was minimal. 
Unexpectedly, in HEL cells a significant decrease in 15-F2t-IsoP levels for all 
concentrations and EOM tested was observed. This pattern was similar to that observed for 
individual c-PAHs and the c-PAH mix, but was even more pronounced. Again, I have not 
found any explanation for these results supported by the experimental work. I can only 
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speculate that changes in the redox status of the cell caused by compounds present in PM 
could induce the reducing environment within the cells, which in turn resulted in the 
decreased levels of lipid peroxidation. This speculation will be further investigated in future 
studies.  
 In HepG2 cells, a significant increase of oxidative damage to DNA and lipids was 
observed for almost all concentrations and types of EOM and for both treatment periods. 
Protein oxidation was induced only after 48 h treatment and generally with the higher tested 
concentrations. This observation might be explained by the fact that carbonyl groups are 
relatively difficult to induce compared to other products of oxidative stress and thus they 
may be reflective of more severe oxidative stress (DALLE-DONNE et al. 2003). 
 The c-PAHs content in the three tested EOM was substantially different: the EOM 
from summer 2000 contained the lowest concentration of c-PAHs while the highest 
concentration per mg EOM was present in the winter 2005 EOM (Table 1). One could say 
that in accordance with this data, there are some results with corresponding differences in 
the levels of oxidative stress. For example, 8-oxodG levels induced by 10 µg/ml EOM after 
24 h treatment in HepG2 cells were lowest for the summer 2000 EOM, followed by 
the winter 2001 and with highest levels found for winter 2005. For 15-F2t-IsoP, this trend 
was also observed with the higher concentration of EOM (25 µg/ml). However, this effect 
was restricted only for some markers and treatment periods. It was not found for protein 
oxidation, or for 48 h treatment periods for either marker. Since there was not a similar 
response for B[a]P alone, or for the c-PAH mix, it is probable that other, unidentified 
components of EOM  were responsible for the induction of oxidative stress in HepG2 cells.  
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6 SUMMARY 
 In this master thesis the effect of c-PAHs, their artificial mixture and EOM on 
oxidative damage to macromolecules in two cell lines was investigated. The most important 
conclusions are listed below: 
 The results demonstrate that EOM from urban air particulate matter posses 
the ability to induce oxidative damage to DNA, lipids and proteins in HepG2 cells.  
 Since B[a]P, DB[a,l]P and the artificial mixture of c-PAHs had lower ability to 
cause oxidative damage that was limited only to longer incubation periods, there 
might be some components of EOM other than c-PAHs responsible for increased 
levels of 8-oxodG, 15-F2t-IsoP, and protein carbonyls in EOM-treated HepG2 cells. 
 The response of the two cell lines to the treatment with EOM is substantially 
distinct. In HepG2 cells the increase in oxidative damage to macromolecules 
following the treatment with EOM was observed, in HEL cells this phenomenon 
was not seen. 
 In HepG2 cells, oxidative damage to DNA and lipids was induced already after 24 h 
of incubation with EOM, while protein oxidation was increased after 48 h treatment. 
Because the induction of oxidative damage to individual macromolecules may be 
different, simultaneous analyses of more oxidative stress markers should be 
performed. 
 These conclusions demonstrate that the aims of the master thesis have been 
accomplished.  
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